STOCK TITAN

Addus HomeCare (NASDAQ: ADUS) grows revenue, cash flow and cuts debt

(Moderate)
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

Addus HomeCare Corporation delivered higher results for the three and six months ended June 30, 2026. Net service revenues were $377.4 million for the quarter, up 8.0% from $349.4 million, and $741.0 million for the first half, up 7.8% from $687.2 million. Quarterly net income increased to $27.6 million, a 25.2% rise, and first-half net income reached $52.7 million, up from $43.3 million, with diluted EPS of $1.49 for the quarter and $2.85 year-to-date.

Growth was driven mainly by the personal care segment, which generated $296.0 million in Q2 revenue, supported by organic volume and the HomeCourt, Gold Horses and Helping Hands acquisitions. Hospice revenue rose to $64.2 million on organic growth, while home health revenue edged down to $17.2 million on lower patient volumes. Managed care organizations represented 38.6% of Q2 net service revenues, and Illinois personal care remained a key contributor, with the Illinois Department on Aging accounting for 17.7% of net service revenues in the quarter.

Cash generation and deleveraging were notable. Net cash provided by operating activities for the first half was $92.4 million, compared with $41.5 million a year earlier. Cash increased to $99.6 million, and long-term debt declined to $61.6 million from $121.0 million, after repaying $60.0 million on the revolving credit facility, leaving $577.8 million available to borrow. The company received $6.3 million of ARPA-related state funding in the first half, using $5.6 million primarily for caregiver recruitment and retention, and reported $12.4 million of deferred ARPA funding within government stimulus advances. The discussion highlights recent reimbursement increases in Illinois and Texas, a 2.6% Medicare hospice rate update, a projected 1.3% reduction in Medicare home health payments for 2026, CMS’s new Medicaid access rule with an 80/20 compensation requirement by mid-2030, and a six‑month nationwide moratorium on new Medicare hospice and home health enrollments.

Positive

  • Quarterly net income grew 25.2% to $27.6 million, with diluted EPS rising to $1.49, as revenue gains, stable gross margins and lower interest expense supported stronger profitability.
  • Net cash provided by operating activities for the first half of 2026 increased to $92.4 million from $41.5 million, enhancing internal funding capacity for acquisitions and debt reduction.
  • Long-term debt fell to $61.6 million at June 30, 2026, from $121.0 million at December 31, 2025, after repaying $60.0 million on the revolving credit facility, leaving $577.8 million of borrowing availability.

Negative

  • None.

Filing Explained

As of June 30, 2026, Addus HomeCare had 18,674 thousand shares outstanding versus 18,518 thousand at December 31, 2025. The filing attributes the change to restricted-stock issuances, option exercises, and forfeitures, increasing the share count and reducing existing holders’ percentage ownership absent offsetting changes.

Q2 2026 Net Service Revenues $377.4 million For the three months ended June 30, 2026; up 8.0% from $349.4 million in 2025
Q2 2026 Net Income $27.6 million For the three months ended June 30, 2026; a 25.2% increase over $22.1 million in 2025
H1 2026 Net Service Revenues $741.0 million For the six months ended June 30, 2026; up from $687.2 million in 2025
H1 2026 Net Cash from Operating Activities $92.4 million Net cash provided by operating activities for the six months ended June 30, 2026
Cash Balance $99.566 million Cash at June 30, 2026, compared with $81.617 million at December 31, 2025
Long-Term Debt $61.597 million Long-term debt net of issuance costs at June 30, 2026; down from $120.959 million at December 31, 2025
Shares Outstanding 18,674,300 shares Common stock outstanding as of July 28, 2026
ARPA Deferred Funding $12.4 million Deferred portion of ARPA funding included in Government stimulus advances at June 30, 2026
Patient-Driven Groupings Model medical
"CMS uses the Patient-Driven Groupings Model (“PDGM”) as the case-mix classification model"
Home Health Value-Based Purchasing medical
"Under the nationwide Home Health Value-Based Purchasing (“HHVBP”) Model, home health agencies receive increases or decreases"
Work Opportunity Tax Credit financial
"The Work Opportunity Tax Credit (“WOTC”) is a federal tax credit available to employers for hiring individuals from certain targeted groups"
A work opportunity tax credit is a government tax incentive that lets employers reduce their federal tax bill when they hire people from certain groups that face barriers to employment (for example, veterans, long-term unemployed, or people receiving public assistance). For investors, it matters because these credits lower a company’s effective hiring costs and can improve short‑term cash flow and profitability—think of it like a per‑hire coupon that makes hiring cheaper and can influence labor and growth decisions.
Total Net Leverage Ratio financial
"the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00"
Total net leverage ratio measures how much a company owes after using its cash, compared with the cash it generates in a year; it is usually calculated by subtracting cash from total debt and dividing that net debt by annual operating cash flow or earnings. Investors use it like a debt-to-income check for a household — a higher number means the company may struggle to cover obligations and is riskier, while a lower number suggests more cushion and financial flexibility.
American Rescue Plan Act of 2021 regulatory
"the American Rescue Plan Act of 2021 (“ARPA”) provided for a 10-percentage point increase in federal matching funds"
Ensuring Access to Medicaid Services regulatory
"CMS finalized a rule intended to improve access to services, “Ensuring Access to Medicaid Services”"
Q2 2026 net service revenues $377.4 million up from $349.4 million in Q2 2025 (8.0% increase stated by the company)
Q2 2026 net income $27.6 million up from $22.1 million in Q2 2025 (25.2% increase stated by the company)
H1 2026 net service revenues $741.0 million up from $687.2 million for the six months ended June 30, 2025
H1 2026 net income $52.7 million up from $43.3 million for the six months ended June 30, 2025 (21.7% increase stated by the company)
H1 2026 net cash from operating activities $92.4 million up from $41.5 million for the six months ended June 30, 2025

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How did Addus HomeCare (ADUS) perform financially in Q2 2026?

Addus HomeCare reported $377.4 million in Q2 2026 net service revenues, an 8.0% increase year over year. Net income rose to $27.6 million, up 25.2%, with diluted earnings per share of $1.49 compared with $1.20 in the prior-year quarter.

What were Addus HomeCare (ADUS) revenues by segment in Q2 2026?

In Q2 2026, personal care generated $295.995 million, hospice $64.247 million, and home health $17.175 million in net service revenues. Personal care growth reflected organic volume and recent acquisitions, hospice grew organically, while home health declined mainly due to lower patient volumes.

How strong was Addus HomeCare (ADUS) cash flow and debt position at June 30, 2026?

For the first half of 2026, Addus produced $92.4 million in net cash from operating activities, up from $41.5 million. Cash rose to $99.6 million, and long-term debt declined to $61.6 million, with $577.8 million remaining available under the $650.0 million credit facility.

How dependent is Addus HomeCare (ADUS) on Illinois and key state payors?

Illinois personal care operations represented 32.1% of net service revenues for both the three and six months ended June 30, 2026. The Illinois Department on Aging, the largest payor, accounted for 17.7% of Q2 2026 net service revenues and 13.2% of net accounts receivable at June 30, 2026.

What recent acquisitions has Addus HomeCare (ADUS) completed and how were they funded?

On May 1, 2026, Addus acquired HomeCourt Home Care for approximately $12.2 million, funded with available cash, adding $11.3 million of goodwill in personal care. Earlier 2025 deals (Jacksonville, Great Lakes, Helping Hands, Gold Horses) expanded personal care, hospice and home health, using cash and the revolving credit facility.

What reimbursement changes could affect Addus HomeCare (ADUS) in Illinois and Texas?

Illinois increased in‑home care hourly rates to $30.80 and set a minimum wage of $18.75 for direct service workers effective January 1, 2026, with CMS waiver approval through September 30, 2026. Texas raised in‑home care rates to $17.13 per hour effective September 1, 2025.

How is Addus HomeCare (ADUS) affected by ARPA funding and the new CMS Medicaid access rule?

Through June 30, 2026, Addus received $6.3 million in ARPA-related state funding and utilized $5.6 million, mainly for caregiver recruitment and retention, with $12.4 million deferred. CMS’s “Ensuring Access to Medicaid Services” rule will require at least 80% of certain HCBS payments go to direct care worker compensation by mid‑2030.
0001468328 Addus HomeCare Corp false --12-31 Q2 2026 0.001 0.001 40,000 40,000 18,674 18,674 18,518 18,518 3 3 1.6 1 20 3 15 3 15 1 20 3 5 6 10 2.3 http://fasb.org/us-gaap/2026#GeneralAndAdministrativeExpense http://fasb.org/us-gaap/2026#GeneralAndAdministrativeExpense July 30, 2028 3.75 4.25 0 http://fasb.org/srt/2026#ChiefExecutiveOfficerMember 3 3 The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management. false false false false Included $2.3 million related to the New York Asset Sale deferred payments as of June 30, 2026 and December 31, 2025. Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense. 00014683282026-01-012026-06-30 xbrli:shares 00014683282026-07-28 thunderdome:item iso4217:USD 00014683282026-06-30 00014683282025-12-31 iso4217:USDxbrli:shares 00014683282026-04-012026-06-30 00014683282025-04-012025-06-30 00014683282025-01-012025-06-30 0001468328us-gaap:CommonStockMember2026-03-31 0001468328us-gaap:AdditionalPaidInCapitalMember2026-03-31 0001468328us-gaap:RetainedEarningsMember2026-03-31 00014683282026-03-31 0001468328us-gaap:CommonStockMember2026-04-012026-06-30 0001468328us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-30 0001468328us-gaap:RetainedEarningsMember2026-04-012026-06-30 0001468328us-gaap:CommonStockMember2026-06-30 0001468328us-gaap:AdditionalPaidInCapitalMember2026-06-30 0001468328us-gaap:RetainedEarningsMember2026-06-30 0001468328us-gaap:CommonStockMember2025-12-31 0001468328us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001468328us-gaap:RetainedEarningsMember2025-12-31 0001468328us-gaap:CommonStockMember2026-01-012026-06-30 0001468328us-gaap:AdditionalPaidInCapitalMember2026-01-012026-06-30 0001468328us-gaap:RetainedEarningsMember2026-01-012026-06-30 0001468328us-gaap:CommonStockMember2025-03-31 0001468328us-gaap:AdditionalPaidInCapitalMember2025-03-31 0001468328us-gaap:RetainedEarningsMember2025-03-31 00014683282025-03-31 0001468328us-gaap:CommonStockMember2025-04-012025-06-30 0001468328us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-30 0001468328us-gaap:RetainedEarningsMember2025-04-012025-06-30 0001468328us-gaap:CommonStockMember2025-06-30 0001468328us-gaap:AdditionalPaidInCapitalMember2025-06-30 0001468328us-gaap:RetainedEarningsMember2025-06-30 00014683282025-06-30 0001468328us-gaap:CommonStockMember2024-12-31 0001468328us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001468328us-gaap:RetainedEarningsMember2024-12-31 00014683282024-12-31 0001468328us-gaap:CommonStockMember2025-01-012025-06-30 0001468328us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-30 0001468328us-gaap:RetainedEarningsMember2025-01-012025-06-30 xbrli:pure 0001468328us-gaap:EmployeeStockOptionMember2026-04-012026-06-30 0001468328us-gaap:EmployeeStockOptionMember2025-04-012025-06-30 0001468328us-gaap:EmployeeStockOptionMember2026-01-012026-06-30 0001468328us-gaap:EmployeeStockOptionMember2025-01-012025-06-30 0001468328us-gaap:RestrictedStockMember2026-04-012026-06-30 0001468328us-gaap:RestrictedStockMember2025-04-012025-06-30 0001468328us-gaap:RestrictedStockMember2026-01-012026-06-30 0001468328us-gaap:RestrictedStockMember2025-01-012025-06-30 0001468328adus:NewYorkAssetSaleMember2024-05-20 0001468328adus:NewYorkAssetSaleMember2024-05-202024-05-20 0001468328adus:NewYorkAssetSaleMember2024-10-012024-10-31 0001468328adus:NewYorkAssetSaleMember2024-01-012024-12-31 0001468328adus:NewYorkAssetSaleMember2026-01-012026-06-30 utr:Y 0001468328adus:HospiceSegmentMember2025-12-31 0001468328adus:PersonalCareSegmentMember2025-12-31 0001468328adus:HomeHealthSegmentMember2025-12-31 0001468328adus:HospiceSegmentMember2026-01-012026-06-30 0001468328adus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328adus:HomeHealthSegmentMember2026-01-012026-06-30 0001468328adus:HospiceSegmentMember2026-06-30 0001468328adus:PersonalCareSegmentMember2026-06-30 0001468328adus:HomeHealthSegmentMember2026-06-30 0001468328adus:HomecourtAcquisitionMember2026-05-012026-05-01 0001468328adus:HomecourtAcquisitionMemberadus:PersonalCareSegmentMember2026-05-012026-05-01 0001468328srt:MinimumMember2026-06-30 0001468328srt:MaximumMember2026-06-30 0001468328us-gaap:CustomerRelationshipsMembersrt:MinimumMember2026-06-30 0001468328us-gaap:CustomerRelationshipsMembersrt:MaximumMember2026-06-30 0001468328us-gaap:CustomerRelationshipsMember2026-06-30 0001468328us-gaap:CustomerRelationshipsMember2025-12-31 0001468328us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2026-06-30 0001468328us-gaap:TrademarksAndTradeNamesMembersrt:MaximumMember2026-06-30 0001468328us-gaap:TrademarksAndTradeNamesMember2026-06-30 0001468328us-gaap:TrademarksAndTradeNamesMember2025-12-31 0001468328us-gaap:NoncompeteAgreementsMembersrt:MinimumMember2026-06-30 0001468328us-gaap:NoncompeteAgreementsMembersrt:MaximumMember2026-06-30 0001468328us-gaap:NoncompeteAgreementsMember2026-06-30 0001468328us-gaap:NoncompeteAgreementsMember2025-12-31 0001468328adus:StateLicensesMembersrt:MinimumMember2026-06-30 0001468328adus:StateLicensesMembersrt:MaximumMember2026-06-30 0001468328adus:StateLicensesMember2026-06-30 0001468328adus:StateLicensesMember2025-12-31 0001468328adus:StateLicensesMember2026-06-30 0001468328adus:StateLicensesMember2025-12-31 0001468328adus:HomecourtAcquisitionMemberadus:StateLicensesMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328adus:HomecourtAcquisitionMemberus-gaap:NoncompeteAgreementsMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328adus:NewYorkAssetSaleMember2026-06-30 0001468328adus:NewYorkAssetSaleMember2025-12-31 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMember2026-06-30 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMember2025-12-31 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMember2024-10-22 0001468328adus:CreditAgreementMember2024-10-22 0001468328adus:CreditAgreementMember2024-10-222024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:MinimumMemberus-gaap:PrimeRateMember2024-10-222024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:MaximumMemberus-gaap:PrimeRateMember2024-10-222024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMemberadus:FederalFundsRateMember2024-10-222024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:MinimumMember2024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:WeightedAverageMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-10-22 0001468328adus:CreditAgreementMembersrt:MinimumMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-10-222024-10-22 0001468328adus:CreditAgreementMembersrt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-10-222024-10-22 0001468328adus:CreditAgreementMembersrt:MinimumMember2024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMembersrt:MaximumMember2024-10-22 0001468328us-gaap:RevolvingCreditFacilityMemberadus:CapitalOneNationalAssociationMember2026-01-012026-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:PersonalCareMember2026-04-012026-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:HospiceMember2026-04-012026-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:HomeHealthMember2026-04-012026-06-30 0001468328us-gaap:OperatingSegmentsMember2026-04-012026-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:PersonalCareMember2025-04-012025-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:HospiceMember2025-04-012025-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:HomeHealthMember2025-04-012025-06-30 0001468328us-gaap:OperatingSegmentsMember2025-04-012025-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:PersonalCareMember2026-01-012026-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:HospiceMember2026-01-012026-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:HomeHealthMember2026-01-012026-06-30 0001468328us-gaap:OperatingSegmentsMember2026-01-012026-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:PersonalCareMember2025-01-012025-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:HospiceMember2025-01-012025-06-30 0001468328us-gaap:OperatingSegmentsMemberadus:HomeHealthMember2025-01-012025-06-30 0001468328us-gaap:OperatingSegmentsMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsMemberadus:PersonalCareSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsMemberadus:PersonalCareSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsMemberadus:PersonalCareSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:PersonalCareSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:PersonalCareSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:PersonalCareSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PrivatePayMemberadus:PersonalCareSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PrivatePayMemberadus:PersonalCareSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PrivatePayMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PrivatePayMemberadus:PersonalCareSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:PersonalCareSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:PersonalCareSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:PersonalCareSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:PersonalCareSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:PersonalCareSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:PersonalCareSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PersonalCareSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PersonalCareSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:PersonalCareSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HospiceSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HospiceSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HospiceSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HospiceSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:HospiceSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:HospiceSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:HospiceSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:CommercialInsuranceMemberadus:HospiceSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HospiceSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HospiceSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HospiceSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HospiceSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HospiceSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HospiceSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HospiceSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HospiceSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HospiceSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HospiceSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HospiceSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HospiceSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HomeHealthSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HomeHealthSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HomeHealthSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:MedicareMemberadus:HomeHealthSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HomeHealthSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HomeHealthSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HomeHealthSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:ManagedCareOrganizationsMemberadus:HomeHealthSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMemberadus:HomeHealthSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMemberadus:HomeHealthSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMemberadus:HomeHealthSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:StateLocalAndOtherGovernmentalProgramsExcludingMedicareMemberadus:HomeHealthSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HomeHealthSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HomeHealthSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HomeHealthSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:OtherMemberadus:HomeHealthSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HomeHealthSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HomeHealthSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HomeHealthSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:CustomerConcentrationRiskMemberadus:HomeHealthSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:IL2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:IL2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:IL2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:IL2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:TX2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:TX2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:TX2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:TX2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:NM2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:NM2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:NM2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberstpr:NM2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberadus:AllOtherStatesMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberadus:AllOtherStatesMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberadus:AllOtherStatesMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMemberadus:AllOtherStatesMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:PersonalCareSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:OH2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:OH2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:OH2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:OH2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:IL2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:IL2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:IL2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:IL2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:NM2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:NM2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:NM2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberstpr:NM2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberadus:AllOtherStatesMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberadus:AllOtherStatesMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberadus:AllOtherStatesMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMemberadus:AllOtherStatesMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HospiceSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:NM2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:NM2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:NM2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:NM2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:TN2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:TN2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:TN2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:TN2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:IL2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:IL2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:IL2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMemberstpr:IL2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMemberus-gaap:GeographicConcentrationRiskMemberadus:HomeHealthSegmentMember2025-01-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberstpr:IL2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberstpr:IL2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2026-04-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2025-04-012025-06-30 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2026-01-012026-06-30 0001468328us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2025-01-012025-06-30 0001468328us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2026-01-012026-06-30 0001468328us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberadus:IllinoisDepartmentOnAgingMember2025-01-012025-12-31
 
 

 

Table of Contents


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM 10-Q


 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2026

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from             to             

Commission file number 001-34504


ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)


 

 

Delaware

20-5340172

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

  

6303 Cowboys Way, Suite 600

Frisco, TX

75034

(Address of principal executive offices)

(Zip Code)

(469) 535-8200

(Registrants telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

ADUS

The Nasdaq Stock Market, LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

1

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer

Accelerated Filer

Non-Accelerated Filer

Smaller Reporting Company

Emerging Growth Company

  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☒

 

As of July 28, 2026, Addus HomeCare Corporation had 18,674,300 shares of Common Stock outstanding.

 


 

2

 

 

ADDUS HOMECARE CORPORATION

 

FORM 10-Q

 

INDEX

 

PART I. FINANCIAL INFORMATION

4

   

Item 1. Financial Statements (Unaudited)

4

   

Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025

4

   

Condensed Consolidated Statements of Income For the Three and Six Months Ended June 30, 2026 and 2025

5

   

Condensed Consolidated Statements of Stockholders Equity For the Three and Six Months Ended June 30, 2026 and 2025

6

   

Condensed Consolidated Statements of Cash Flows For the Six Months Ended June 30, 2026 and 2025

8

   

Notes to Condensed Consolidated Financial Statements

9

   

Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations

22

   

Item 3. Quantitative and Qualitative Disclosures About Market Risk

39

   

Item 4. Controls and Procedures

39

   

PART II. OTHER INFORMATION

40

   

Item 1. Legal Proceedings

40

   

Item 1A. Risk Factors

40

   

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

40

   

Item 3. Defaults Upon Senior Securities

40

   

Item 4. Mine Safety Disclosures

40

   

Item 5. Other Information

40

   

Item 6. Exhibits

41

 

3

 

 

PART I FINANCIAL INFORMATION

 

Item 1.         Financial Statements

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

As of June 30, 2026 and December 31, 2025

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

 

  

June 30, 2026

  

December 31, 2025

 

Assets

        

Current assets

        

Cash

 $99,566  $81,617 

Accounts receivable, net of allowances for credit losses

  145,123   151,695 

Prepaid expenses and other current assets

  39,461   36,179 

Total current assets

  284,150   269,491 

Property and equipment, net of accumulated depreciation and amortization

  23,851   24,998 

Other assets

        

Goodwill

  1,008,053   996,696 

Intangibles, net of accumulated amortization

  99,398   102,410 

Operating lease assets, net

  41,034   43,713 

Total other assets

  1,148,485   1,142,819 

Total assets

 $1,456,486  $1,437,308 

Liabilities and stockholders' equity

        

Current liabilities

        

Accounts payable

 $18,038  $16,832 

Accrued payroll

  76,834   65,941 

Accrued expenses

  34,923   28,191 

Operating lease liabilities, current portion

  13,059   13,144 

Government stimulus advances

  12,383   11,699 

Accrued workers' compensation insurance

  12,911   13,680 

Total current liabilities

  168,148   149,487 

Long-term liabilities

        

Long-term debt, net of debt issuance costs

  61,597   120,959 

Long-term operating lease liabilities

  34,164   37,259 

Deferred income tax

  44,366   44,065 

Other long-term liabilities

  54   235 

Total long-term liabilities

  140,181   202,518 

Total liabilities

 $308,329  $352,005 

Stockholders' equity

        

Common stock—$.001 par value; 40,000 authorized and 18,674 and 18,518 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively

 $19  $18 

Additional paid-in capital

  623,122   612,945 

Retained earnings

  525,016   472,340 

Total stockholders' equity

  1,148,157   1,085,303 

Total liabilities and stockholders' equity

 $1,456,486  $1,437,308 

 

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

 

4

 

 

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the Three and Six Months Ended June 30, 2026 and 2025

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

 

   

For the Three Months Ended

   

For the Six Months Ended

 
   

June 30,

   

June 30,

 
   

2026

   

2025

   

2026

   

2025

 

Net service revenues

  $ 377,417     $ 349,443     $ 741,028     $ 687,151  

Cost of service revenues

    255,857       235,566       503,595       465,597  

Gross profit

    121,560       113,877       237,433       221,554  

General and administrative expenses

    78,493       77,077       156,264       150,297  

Depreciation and amortization

    4,125       3,913       8,155       7,856  

Total operating expenses

    82,618       80,990       164,419       158,153  

Operating income

    38,942       32,887       73,014       63,401  

Interest income

    (566 )     (583 )     (1,076 )     (1,085 )

Interest expense

    1,724       3,525       3,875       7,543  

Total interest expense, net

    1,158       2,942       2,799       6,458  

Income before income taxes

    37,784       29,945       70,215       56,943  

Income tax expense

    10,177       7,893       17,539       13,663  

Net income

  $ 27,607     $ 22,052     $ 52,676     $ 43,280  

Net income per common share

                               

Basic income per share

  $ 1.51     $ 1.22     $ 2.89     $ 2.40  

Diluted income per share

  $ 1.49     $ 1.20     $ 2.85     $ 2.36  

Weighted average number of common shares and potential common shares outstanding:

                               

Basic

    18,292       18,045       18,243       18,011  

Diluted

    18,472       18,332       18,499       18,340  

 

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

 

5

 

 

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three and Six Months Ended June 30, 2026

(Amounts and Shares in Thousands)

(Unaudited)

 

   

For the Three Months Ended June 30, 2026

 
                   

Additional

           

Total

 
   

Common Stock

   

Paid-in

   

Retained

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Earnings

   

Equity

 

Balance at April 1, 2026

    18,664     $ 19     $ 618,732     $ 497,409     $ 1,116,160  

Issuance of shares of common stock under restricted stock award agreements

    10                          

Forfeiture of shares of common stock under restricted stock award agreements

                             

Stock-based compensation

                4,390             4,390  

Shares issued for exercise of stock options

                             

Net income

                      27,607       27,607  

Balance at June 30, 2026

    18,674     $ 19     $ 623,122     $ 525,016     $ 1,148,157  

 

 

   

For the Six Months Ended June 30, 2026

 
                   

Additional

           

Total

 
   

Common Stock

   

Paid-in

   

Retained

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Earnings

   

Equity

 

Balance at January 1, 2026

    18,518     $ 18     $ 612,945     $ 472,340     $ 1,085,303  

Issuance of shares of common stock under restricted stock award agreements

    136       1                   1  

Forfeiture of shares of common stock under restricted stock award agreements

    (1 )                        

Stock-based compensation

                9,390             9,390  

Shares issued for exercise of stock options

    21             787             787  

Net income

                      52,676       52,676  

Balance at June 30, 2026

    18,674     $ 19     $ 623,122     $ 525,016     $ 1,148,157  

 

6

 

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three and Six Months Ended June 30, 2025

(Amounts and Shares in Thousands)

(Unaudited)

 

   

For the Three Months Ended June 30, 2025

 
                   

Additional

           

Total

 
   

Common Stock

   

Paid-in

   

Retained

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Earnings

   

Equity

 

Balance at April 1, 2025

    18,399     $ 18     $ 597,706     $ 397,658     $ 995,382  

Issuance of shares of common stock under restricted stock award agreements

    10                          

Forfeiture of shares of common stock under restricted stock award agreements

    (2 )                        

Stock-based compensation

                4,420             4,420  

Shares issued for exercise of stock options

                             

Net income

                      22,052       22,052  

Balance at June 30, 2025

    18,407     $ 18     $ 602,126     $ 419,710     $ 1,021,854  

 

   

For the Six Months Ended June 30, 2025

 
                   

Additional

           

Total

 
   

Common Stock

   

Paid-in

   

Retained

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Earnings

   

Equity

 

Balance at January 1, 2025

    18,148     $ 18     $ 594,044     $ 376,430     $ 970,492  

Issuance of shares of common stock under restricted stock award agreements

    237                          

Forfeiture of shares of common stock under restricted stock award agreements

    (3 )                        

Stock-based compensation

                7,590             7,590  

Shares issued for exercise of stock options

    25             492             492  

Net income

                      43,280       43,280  

Balance at June 30, 2025

    18,407     $ 18     $ 602,126     $ 419,710     $ 1,021,854  

 

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

 

7

 

 

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Six Months Ended June 30, 2026 and 2025

(Amounts in Thousands)

(Unaudited)

 

   

For the Six Months Ended

 
   

June 30,

 
   

2026

   

2025

 

Cash flows from operating activities:

               

Net income

  $ 52,676     $ 43,280  

Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:

               

Depreciation and amortization

    8,155       7,856  

Deferred income taxes

    301       467  

Stock-based compensation

    9,390       7,590  

Amortization of debt issuance costs under the credit facility

    656       638  

Provision for credit losses

    759       681  

Gain on disposal of assets

    (13 )     (8 )

Loss on termination of operating leases

    7       19  

Changes in operating assets and liabilities, net of acquisitions:

               

Accounts receivable

    5,834       (15,936 )

Prepaid expenses and other current assets

    (3,397 )     2,856  

Government stimulus advances

    684       (3,312 )

Accounts payable

    649       (12,844 )

Accrued payroll

    10,893       6,446  

Accrued expenses and other long-term liabilities

    5,782       3,745  

Net cash provided by operating activities

    92,376       41,478  

Cash flows from investing activities:

               

Acquisitions of businesses, net of cash acquired

    (12,182 )     (3,350 )

Purchases of property and equipment

    (3,050 )     (3,136 )

Proceeds received from disposal of assets

    35       18  

Proceeds received from previous acquisition

          2,937  

Proceeds received from divestiture of business

          3,848  

Net cash (used in) provided by investing activities

    (15,197 )     317  

Cash flows from financing activities:

               

Payments on revolver — credit facility

    (60,000 )     (50,000 )

Payments for debt issuance costs under the credit facility

    (18 )     (22 )

Cash received from exercise of stock options

    788       492  

Net cash used in financing activities

    (59,230 )     (49,530 )

Net change in cash

    17,949       (7,735 )

Cash, at beginning of period

    81,617       98,911  

Cash, at end of period

  $ 99,566     $ 91,176  

Supplemental disclosures of cash flow information:

               

Cash paid for interest

  $ 3,218     $ 7,019  

Cash paid for income taxes

    5,288       4,861  

 

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

 

8

 

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

 

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

 

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us”, or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill, or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The Company’s payors include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals.

 

 

Basis of Presentation

 

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of  December 31, 2025 has been derived from the Company’s audited financial statements for the year ended  December 31, 2025 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended  December 31, 2025 included in our Annual Report on Form 10-K, as amended (“Annual Report on Form 10-K”), which includes information and disclosures not included herein.

 

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

 

 

Principles of Consolidation

 

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

   

 

2. Summary of Significant Accounting Policies

 

Estimates

 

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

 

9

 

Computation of Weighted Average Shares

 

The following table sets forth the computation of basic and diluted common shares:

 

  

For the Three Months Ended June 30,

  

For the Six Months Ended June 30,

 
  

(Amounts in thousands)

  

(Amounts in thousands)

 
  

2026

  

2025

  

2026

  

2025

 

Weighted average number of shares outstanding for basic per share calculation

  18,292   18,045   18,243   18,011 

Effect of dilutive potential shares:

                

Stock options

  122   219   136   221 

Restricted stock awards

  58   68   120   108 

Adjusted weighted average shares for diluted per share calculation

  18,472   18,332   18,499   18,340 

Anti-dilutive shares:

                

Stock options

            

Restricted stock awards

  199   9   122   9 

 

 

Recently Adopted Accounting Pronouncements

 

In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-09 during the year ended  December 31, 2025. Adoption of the standard did not have a material impact on the Company’s consolidated financial statements and expanded income tax disclosures.

 

In July 2025, the FASB issued ASU 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets, which replaces the incurred-loss model with a forward-looking current expected credit loss model that requires recognition of lifetime expected credit losses on financial assets measured at amortized cost and certain off-balance-sheet credit exposures (including trade accounts receivable and contract assets), using historical experience, current conditions, and reasonable and supportable forecasts. ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The disclosure updates should be applied prospectively. The Company adopted ASU 2025-05 during the three months ended March 31, 2026. Adoption did not have a material impact on the Company’s consolidated financial statements. 

 

Recently Issued Accounting Pronouncements

 

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.

 

In  September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The new guidance intends to modernize the guidance related to internal-use software costs to reflect current software development methods. It requires entities to begin capitalizing software costs when management authorizes and commits to funding the software project, and it is probable the project will be completed and the software will be used for its intended purpose. ASU 2025-06 is effective for fiscal years beginning after  December 15, 2027, and interim periods within those fiscal years, and  may be adopted using a prospective, retrospective, or modified transition approach. Early adoption is permitted. The Company is currently evaluating the impact on its consolidated financial statements.

 

10

 

In  December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which provides guidance on the recognition, measurement, and presentation of government grants. ASU 2025-10 is effective for fiscal years beginning after  December 15, 2028, and interim periods within those fiscal years, and permits modified prospective, modified retrospective, or full retrospective adoption, with early adoption permitted. The Company has evaluated the guidance and does not expect adoption to have a material impact on its consolidated financial statements or related disclosures.

 

In  December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies certain interim reporting guidance. ASU 2025-11 is effective for fiscal years beginning after  December 15, 2027, and interim periods within those fiscal years. The Company has evaluated the guidance and does not expect adoption to have a material impact on its consolidated financial statements.

 

 

3. Divestiture

 

Effective May 20, 2024, the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $23.0 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The purchase price included 50% cash consideration, paid out as an initial payment of $4.6 million and $6.9 million paid pro rata as a deferred payment as caregivers are transferred, and 50% in the form of contingent consideration for the Company’s New York Consumer Directed Personal Assistance Program (“CDPAP”) business. No amount was recorded related to the CDPAP business contingent consideration. The Company entered into a consulting agreement with the purchaser effective May 20, 2024, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale was occurring over time. The Company determined that the consulting agreement gave it the ability to control the business until October 2024, when the Company determined that it no longer controlled the business as it transferred more than 50% of the clients and caregivers and therefore qualified for sale consideration of the New York Asset Sale. As a result, the Company deconsolidated the results of its New York operations and recorded a gain on divestiture of $3.7 million during the year ended December 31, 2024. The gain was reflected within general and administrative expenses on the consolidated statement of operations. During the six months ended June 30, 2026, the Company recorded a lease modification reducing operating lease assets and liabilities by $1.6 million.

 

 

4. Leases

 

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:

 

  

June 30, 2026

  

December 31, 2025

 
  

(Amounts in Thousands)

 

Operating lease assets, net

 $41,034  $43,713 
         

Short-term operating lease liabilities

  13,059   13,144 

Long-term operating lease liabilities

  34,164   37,259 

Total operating lease liabilities

 $47,223  $50,403 

 

11

 

Lease Costs

 

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

 

  

For the Three Months Ended June 30,

  

For the Six Months Ended June 30,

 
  

(Amounts in Thousands)

  

(Amounts in Thousands)

 
  

2026

  

2025

  

2026

  

2025

 

Operating lease costs

 $3,599  $3,651  $7,255  $7,308 

Short-term lease costs

  285   271   540   555 

Total lease costs

  3,884   3,922   7,795   7,863 

Less: sublease income

           (226)

Total lease costs, net

 $3,884  $3,922  $7,795  $7,637 

 

Lease Term and Discount Rate

 

Weighted average remaining lease terms and discount rates were as follows:

 

  

June 30, 2026

  

December 31, 2025

 

Operating leases:

        

Weighted average remaining lease term

  4.78   5.05 

Weighted average discount rate

  6.48%  6.37%

 

Maturity of Lease Liabilities

 

Remaining operating lease payments as of  June 30, 2026 were as follows:

 

  

Operating Leases

 
  

(Amounts in Thousands)

 

Due in the 12-month period ended June 30,

    

2027

 $15,526 

2028

  11,808 

2029

  8,470 

2030

  6,523 

2031

  5,612 

Thereafter

  7,559 

Total future minimum rental commitments

  55,498 

Less: Imputed interest

  (8,275)

Total lease liabilities

 $47,223 

 

Supplemental Cash Flows Information

 

  

For the Six Months Ended June 30,

 
  

(Amounts in Thousands)

 
  

2026

  

2025

 

Cash paid for amounts included in the measurement of lease liabilities:

        

Operating cash flows from operating leases

 $8,257  $8,368 
         

Right-of-use assets obtained in exchange for lease obligations:

        

Operating leases

 $5,387  $5,158 

  

12

 
 

5. Goodwill and Intangible Assets

 

A summary of the goodwill by segment and related adjustments is provided below:

 

  

Hospice

  

Personal Care

  

Home Health

  

Total

 
  

(Amounts in Thousands)

 

Goodwill as of December 31, 2025

 $432,866  $468,981  $94,849  $996,696 

Additions for acquisitions

     11,332      11,332 

Adjustments to previously recorded goodwill

  (14)  41   (2)  25 

Goodwill as of June 30, 2026

 $432,852  $480,354  $94,847  $1,008,053 

 

On May 1, 2026, the Company completed its acquisition of substantially all of the assets of an Indiana limited liability company doing business as HomeCourt Home Care for $12.2 million (the “HomeCourt Acquisition”), with funding provided by available cash. With the HomeCourt Acquisition, the Company expanded its personal care segment to Indiana and recognized goodwill in its personal care segment of $11.3 million.

 

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements, and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from three to fifteen years.

 

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:

 

     

June 30, 2026

  

December 31, 2025

 
     

(Amounts in Thousands)

  

(Amounts in Thousands)

 
  

Estimated Useful

  

Gross

  

Accumulated

  

Net

  

Gross

  

Accumulated

  

Net

 
  

Life (years)

  

carrying value

  

amortization

  

carrying value

  

carrying value

  

amortization

  

carrying value

 

Customer and referral relationships

 3 - 15  $34,026  $(33,643) $383  $34,201  $(33,656) $545 

Trade names and trademarks

 1 - 20   57,987   (27,472)  30,515   59,366   (26,535)  32,831 

Non-competition agreement

 3 - 5   7,038   (6,729)  309   6,728   (6,663)  65 

State Licenses

 6 - 10   27,069   (5,508)  21,561   26,529   (4,190)  22,339 

State Licenses

 

Indefinite

   46,630      46,630   46,630      46,630 

Total intangible assets

    $172,750  $(73,352) $99,398  $173,454  $(71,044) $102,410 

 

During the six months ended June 30, 2026, the Company acquired state licenses and a non-competition agreement of $0.6 million and $0.3 million, respectively, in its personal care services segment related to the HomeCourt Acquisition.

 

Amortization expense related to the intangible assets was $2.0 million and $3.9 million for the three and six months ended June 30, 2026, respectively, and $2.0 million and $4.0 million for the three and six months ended June 30, 2025, respectively. The weighted average remaining useful lives of identifiable intangible assets as of  June 30, 2026 was 8.76 years.

  

13

 
 

6. Details of Certain Balance Sheet Accounts

 

Prepaid expenses and other current assets consisted of the following:

 

  

June 30, 2026

  

December 31, 2025

 
  

(Amounts in Thousands)

 

Income tax receivable

 $1,090  $10,520 

Prepaid payroll

  21,419   7,960 

Prepaid workers' compensation and liability insurance

  7,579   5,694 

Prepaid licensing fees

  5,005   4,167 

Workers' compensation insurance receivable

  629   474 

Other (1)

  3,739   7,364 

Total prepaid expenses and other current assets

 $39,461  $36,179 

 

 

(1)

Included $2.3 million related to the New York Asset Sale deferred payments as of June 30, 2026 and December 31, 2025.

 

Accrued expenses consisted of the following:

 

  

June 30, 2026

  

December 31, 2025

 
  

(Amounts in Thousands)

 

Accrued health benefits

 $6,170  $6,643 

Accrued professional fees

  6,304   6,390 

Accrued payroll and other taxes

  5,812   2,242 

Other

  16,637   12,916 

Total accrued expenses

 $34,923  $28,191 

 

 

7. ARPA Spending Plans

 

To mitigate the fiscal effects of the COVID-19 public health emergency, the American Rescue Plan Act of 2021 (“ARPA”) provided for a 10-percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the states satisfied certain conditions. States must submit periodic HCBS spending plans to CMS regarding the federal and state funds tied to the increase in federal matching funds. Although states were generally permitted to use the associated state funds by March 31, 2025, CMS granted extensions to several states and some state spending plans continue through September 30, 2026.

 

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company participates include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

 

During the three and six months ended June 30, 2026, the Company received additional state funding provided by the ARPA of $0.1 million and $6.3 million, respectively. Of the total state funding received by the Company pursuant to the ARPA through June 30, 2026, the Company utilized $2.4 million and $5.6 million during the three and six months ended June 30, 2026, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2026, the deferred portion of ARPA funding of $12.4 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

  

14

 
 

8. Long-Term Debt

 

Long-term debt consisted of the following:

 

  

June 30, 2026

  

December 31, 2025

 
  

(Amounts in Thousands)

 

Revolving loan under the credit facility

 $64,335  $124,335 

Less unamortized issuance costs

  (2,738)  (3,376)

Long-term debt

 $61,597  $120,959 

 

Amended and Restated Senior Secured Credit Facility

 

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021, as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023, and as further amended by the Fourth Amendment to Amended and Restated Credit Agreement, dated as of October 22, 2024 (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which incremental loan facility may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2028.

 

Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50%, and (c) the sum of Term Secured Overnight Financing Rate (“SOFR”) (as published by the CME Group Benchmark Administrative Limited) for an interest period of one month for such applicable day (not to be less than 0.00%), plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for the applicable interest period (not to be less than 0.00%). Swing loans may not be SOFR loans.

 

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions, and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters.

 

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

 

15

 

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare  may make distributions to the Company in an amount that does not exceed $10.0 million in any year absent an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business. 

 

During the six months ended June 30, 2026, the Company did not draw on its credit facility and repaid $60.0 million under the revolving credit facility.

 

As of June 30, 2026, the Company had a total of $64.3 million of revolving loans, with an interest rate of 5.40%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $7.9 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $650.0 million of capacity and $577.8 million available for borrowing under its credit facility. As of December 31, 2025, the Company had a total of $124.3 million of revolving loans, with an interest rate of 5.48%, outstanding on its credit facility.

 

As of June 30, 2026, the Company was in compliance with all financial covenants under the Credit Agreement.

 

9. Income Taxes

 

The effective income tax rates were 26.9% and 26.4% for the three months ended June 30, 2026 and 2025, respectively. The effective income tax rates were 25.0% and 24.0% for the six months ended June 30, 2026 and 2025, respectively.

 

For the three months ended June 30, 2026, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation and an excess tax expense, partially offset by the use of federal employment tax credits. The Work Opportunity Tax Credit (“WOTC”) is a federal tax credit available to employers for hiring individuals from certain targeted groups. The Company has historically benefited from this credit; however, because the program expired on December 31, 2025, and had not been renewed as of January 1, 2026, the effective income tax rate for the current quarter includes only the benefit associated with employees hired on or before December 31, 2025. For both the three months ended June 30, 2026 and 2025, the effective tax rates were inclusive of an excess tax benefit of 0.0% and 0.1%, respectively. The excess tax expense and tax benefit are discrete items, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense results if the Company’s cumulative costs of the award recognized exceed the income tax deduction, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction.

 

10. Commitments and Contingencies

 

Legal Proceedings

 

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

 

It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

 

 

11. Segment Information

 

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision maker (“CODM”). The Company identifies its Chief Executive Officer and Chief Operating Officer together as CODMs to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three business segments providing in-home services.

 

16

 

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy.

 

The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

 

The CODMs do not review disaggregated assets by segment. The measure of segment assets is reported on the balance sheet as total consolidated assets.

 

The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements.

 

  

For the Three Months Ended June 30, 2026

 
  

(Amounts in Thousands)

 
  

Personal Care

  

Hospice

  

Home Health

  

Total

 

Net service revenues

 $295,995  $64,247  $17,175  $377,417 

Direct service personnel

  209,890   29,761   9,203   248,854 

General and administrative salaries, wages and benefits

  19,490   12,282   3,600   35,372 

Other segment items (1)

  6,235   10,099   1,085   17,419 

Segment operating income

  60,380   12,105   3,287   75,772 

Segment reconciliation:

                

Items not allocated at segment level:

                

Other general and administrative expenses

              32,705 

Depreciation and amortization

              4,125 

Interest income

              (566)

Interest expense

              1,724 

Income before income taxes

             $37,784 

 

 

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

 

  

For the Three Months Ended June 30, 2025

 
  

(Amounts in Thousands)

 
  

Personal Care

  

Hospice

  

Home Health

  

Total

 

Net service revenues

 $269,183  $62,212  $18,048  $349,443 

Direct service personnel

  192,868   26,177   9,451   228,496 

General and administrative salaries, wages and benefits

  18,407   11,448   3,029   32,884 

Other segment items (1)

  6,268   9,765   1,186   17,219 

Segment operating income

  51,640   14,822   4,382   70,844 

Segment reconciliation:

                

Items not allocated at segment level:

                

Other general and administrative expenses

              34,044 

Depreciation and amortization

              3,913 

Interest income

              (583)

Interest expense

              3,525 

Income before income taxes

             $29,945 

 

17

 
 

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense.

 

  

For the Six Months Ended June 30, 2026

 
  

(Amounts in Thousands)

 
  

Personal Care

  

Hospice

  

Home Health

  

Total

 

Net service revenues

 $577,089  $130,032  $33,907  $741,028 

Direct service personnel

  412,762   58,929   18,037   489,728 

General and administrative salaries, wages and benefits

  38,788   24,444   7,198   70,430 

Other segment items (1)

  12,293   19,902   2,222   34,417 

Segment operating income

  113,246   26,757   6,450   146,453 

Segment reconciliation:

                

Items not allocated at segment level:

                

Other general and administrative expenses

              65,284 

Depreciation and amortization

              8,155 

Interest income

              (1,076)

Interest expense

              3,875 

Income before income taxes

             $70,215 

 

 

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

 

  

For the Six Months Ended June 30, 2025

 
  

(Amounts in Thousands)

 
  

Personal Care

  

Hospice

  

Home Health

  

Total

 

Net service revenues

 $527,469  $123,649  $36,033  $687,151 

Direct service personnel

  379,518   52,382   19,864   451,764 

General and administrative salaries, wages and benefits

  36,647   22,427   6,308   65,382 

Other segment items (1)

  12,073   19,401   2,465   33,939 

Segment operating income

  99,231   29,439   7,396   136,066 

Segment reconciliation:

                

Items not allocated at segment level:

                

Other general and administrative expenses

              64,809 

Depreciation and amortization

              7,856 

Interest income

              (1,085)

Interest expense

              7,543 

Income before income taxes

             $56,943 

 

 

(1)

Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense

 

18

 
 

12. Significant Payors

 

The Company’s revenue by payor type was as follows:

 

Personal Care Segment

 

For the Three Months Ended June 30,

  

For the Six Months Ended June 30,

 
  

2026

  

2025

  

2026

  

2025

 
      

% of Segment

      

% of Segment

      

% of Segment

      

% of Segment

 
  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

 
  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

 

State, local and other governmental programs

 $148,822   50.3% $138,506   51.4% $288,457   50.0% $271,410   51.4%

Managed care organizations

  139,285   47.1   121,900   45.3   272,959   47.3   238,907   45.3 

Private pay

  6,494   2.2   7,292   2.7   12,721   2.2   14,268   2.7 

Commercial insurance

  1,189   0.4   1,334   0.5   2,295   0.4   2,494   0.5 

Other

  205      151   0.1   657   0.1   390   0.1 

Total personal care segment net service revenues

 $295,995   100.0% $269,183   100.0% $577,089   100.0% $527,469   100.0%

 

Hospice Segment

 

For the Three Months Ended June 30,

  

For the Six Months Ended June 30,

 
  

2026

  

2025

  

2026

  

2025

 
      

% of Segment

      

% of Segment

      

% of Segment

      

% of Segment

 
  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

 
  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

 

Medicare

 $60,020   93.4% $57,846   93.0% $122,111   93.9% $114,638   92.7%

Commercial insurance

  1,910   3.0   1,997   3.2   3,722   2.9   4,375   3.5 

Managed care organizations

  1,920   3.0   2,001   3.2   3,420   2.6   4,029   3.3 

Other

  397   0.6   368   0.6   779   0.6   607   0.5 

Total hospice segment net service revenues

 $64,247   100.0% $62,212   100.0% $130,032   100.0% $123,649   100.0%

 

Home Health Segment

 

For the Three Months Ended June 30,

  

For the Six Months Ended June 30,

 
  

2026

  

2025

  

2026

  

2025

 
      

% of Segment

      

% of Segment

      

% of Segment

      

% of Segment

 
  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

 
  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

 

Medicare

 $10,903   63.5% $12,517   69.4% $21,128   62.3% $25,094   69.7%

Managed care organizations

  4,414   25.7   4,264   23.6   8,381   24.7   8,072   22.4 

State, local and other governmental programs (excluding Medicare)

  1,318   7.7   796   4.4   3,369   9.9   1,884   5.2 

Other

  540   3.1   471   2.6   1,029   3.1   983   2.7 

Total home health segment net service revenues

 $17,175   100.0% $18,048   100.0% $33,907   100.0% $36,033   100.0%

 

19

 

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, Ohio, Tennessee, and Texas. The percentages of segment revenue for each of these significant states for the three and six months ended June 30, 2026 and 2025, respectively, were as follows:

 

Personal Care Segment

 

For the Three Months Ended June 30,

  

For the Six Months Ended June 30,

 
  

2026

  

2025

  

2026

  

2025

 
      

% of Segment

      

% of Segment

      

% of Segment

      

% of Segment

 
  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

 
  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

 

Illinois

 $121,089   40.9% $115,226   42.8% $237,839   41.2% $226,640   43.0%

Texas

  59,139   20.0   52,464   19.5   116,529   20.2   102,324   19.4 

New Mexico

  31,962   10.8   28,987   10.8   62,452   10.8   57,292   10.9 

All other states

  83,805   28.3   72,506   26.9   160,269   27.8   141,213   26.7 

Total personal care segment net service revenues

 $295,995   100.0% $269,183   100.0% $577,089   100.0% $527,469   100.0%

 

Hospice Segment

 

For the Three Months Ended June 30,

  

For the Six Months Ended June 30,

 
  

2026

  

2025

  

2026

  

2025

 
      

% of Segment

      

% of Segment

      

% of Segment

      

% of Segment

 
  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

 
  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

 

Ohio

 $24,207   37.7% $23,204   37.3% $50,674   39.0% $46,391   37.5%

Illinois

  13,708   21.3   14,419   23.2   28,047   21.6   28,983   23.4 

New Mexico

  8,475   13.2   8,184   13.2   16,346   12.6   16,097   13.0 

All other states

  17,857   27.8   16,405   26.3   34,965   26.8   32,178   26.1 

Total hospice segment net service revenues

 $64,247   100.0% $62,212   100.0% $130,032   100.0% $123,649   100.0%

 

Home Health Segment

 

For the Three Months Ended June 30,

  

For the Six Months Ended June 30,

 
  

2026

  

2025

  

2026

  

2025

 
      

% of Segment

      

% of Segment

      

% of Segment

      

% of Segment

 
  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

  

Amount

  

Net Service

 
  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

  

(in Thousands)

  

Revenues

 

New Mexico

 $9,166   53.4% $8,737   48.4% $17,705   52.2% $17,292   48.0%

Tennessee

  6,533   38.0   7,322   40.6   13,417   39.6   14,820   41.1 

Illinois

  1,476   8.6   1,989   11.0   2,785   8.2   3,921   10.9 

Total home health segment net service revenues

 $17,175   100.0% $18,048   100.0% $33,907   100.0% $36,033   100.0%

 

20

 

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state, and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 32.1% and 33.0% of our net service revenues for both the three and six months ended  June 30, 2026 and 2025, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 17.7% and 18.6% of the Company’s net service revenues for the three months ended  June 30, 2026 and 2025, respectively, and accounted for 17.8% and 18.6% of the Company’s net service revenues for the six months ended June 30, 2026 and 2025, respectively.

 

The related receivables due from the Illinois Department on Aging represented 13.2% and 25.2% of the Company’s net accounts receivable at  June 30, 2026 and December 31, 2025, respectively.

 

21

 
 

ITEM 2.       MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like believes, belief, expects, plans, anticipates, intends, projects, estimates, may, might, would, should, and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the impact of macroeconomic conditions, including inflation and interest rates, legislative and political developments, including federal government shutdowns, any lapse in appropriations and any hold on or cancellation of congressionally authorized spending or interruptions in the distribution of government funds, trade policies and tensions, including changes in, or the imposition of, tariffs and/or trade barriers and the economic impacts, volatility and uncertainty resulting therefrom, and the potential adverse effects of current conditions; business disruptions due to inclement weather, natural disasters, acts of terrorism, military conflicts, pandemics, civil insurrection or social unrest; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates, and the timeliness of reimbursements received under government programs; the implementation of new, and possible changes to existing, federal and state laws or regulations, or our failure to comply with such laws or regulations or comply on a timely basis; the impact of decisions of the U.S. Supreme Court regarding the actions of federal agencies; changes in the executive branch of the federal government; changes in the structure and administration of, and funding for, federal and state agencies and programs; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to overall economic conditions and deficit or spending reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches, cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of the markets for our services, including our expectations regarding the markets for our services; eligibility standards, moratoria on new provider enrollments and limits on services imposed through legislation or by governmental agencies or other third-party payors; the potential for litigation, audits, and investigations; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating, and integrating acquisition opportunities and expanding into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality, and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates;  and various other matters, many of which are beyond our control. In addition, these forward-looking statements are subject to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2025, filed with the SEC. You should carefully review all of these factors. Moreover, our business may be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions. These forward-looking statements were based on information, plans, and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.

 

22

 

Overview

 

We are a home care services provider operating three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care organizations accounted for 38.6% and 36.7% of our net service revenues during the three months ended June 30, 2026 and 2025, respectively, and 38.4% and 36.5% of our net service revenues during the six months ended June 30, 2026 and 2025, respectively.

 

A summary of certain consolidated financial results is provided in the table below.

 

   

For the Three Months Ended June 30,

   

For the Six Months Ended June 30,

 
   

2026

   

2025

   

2026

   

2025

 

Net service revenues by segment:

 

(Amounts in Thousands)

   

(Amounts in Thousands)

 

Personal care

  $ 295,995     $ 269,183     $ 577,089     $ 527,469  

Hospice

    64,247       62,212       130,032       123,649  

Home health

    17,175       18,048       33,907       36,033  

Total net service revenue

  $ 377,417     $ 349,443     $ 741,028     $ 687,151  
                                 

Net income

  $ 27,607     $ 22,052     $ 52,676     $ 43,280  

 

As of June 30, 2026, we provided our services in 24 states through 264 offices. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes, and hospice facilities.

 

Acquisitions

 

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets or facilitating our entry into new markets where in-home care has been moving to managed care organizations or that present other strategic opportunities.

 

On January 1, 2025, the Company completed its acquisition of its Jacksonville affiliate (the “Jacksonville Acquisition”), for approximately $0.8 million, with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

 

On March 1, 2025, the Company completed its acquisition of the assets of Great Lakes Home Care Unlimited, LLC (the “Great Lakes Acquisition”), for $2.6 million, with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

 

On August 1, 2025, the Company completed its acquisition of Helping Hands Home Care Service, Inc. (the “Helping Hands Acquisition”), for approximately $21.4 million, with funding through the Company’s revolving credit facility and available cash. With the Helping Hands Acquisition, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania and recognized goodwill in its personal care segment of $19.0 million.

 

On October 1, 2025, the Company completed its acquisition of Gold Horses, LLC (the “Gold Horses Acquisition”), for approximately $7.4 million, with funding provided by available cash. With the Gold Horses Acquisition, the Company expanded its services within its personal care segment in Texas and recognized goodwill in its personal care segment of $7.4 million.

 

On May 1, 2026, the Company completed its acquisition of HomeCourt Home Care (the “HomeCourt Acquisition”), for approximately $12.2 million, with funding provided by available cash. With the HomeCourt Acquisition, the Company expanded its services within its personal care segment to Indiana and recognized goodwill in its personal care segment of $11.3 million.

 

New York Asset Sale

 

Effective May 20, 2024, we entered into the New York Asset Sale. The Company entered into a consulting agreement with the purchaser, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale was occurring over time. In connection with this transaction, the Company ceased operations in New York. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

 

23

 

Recruiting

 

As the labor market continues to be tight and unemployment remains at low levels, the competition for new caregivers, including skilled healthcare staff, and support staff continues to be significant. In addition, the United States economy continues to experience inflationary pressures. To the extent that we continue to experience a shortage of caregivers, it may hinder our ability to fully meet the continuing demand for both our non-clinical and clinical services.

 

Revenue by Payor and Significant States

 

Our payors are principally federal, state, and local governmental agencies and managed care organizations. The federal, state, and local programs under which the agencies operate are subject to legislative and budgetary changes and other risks that can influence reimbursement rates. We have experienced a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.

 

Our revenue by payor and significant states by segment were as follows:

 

Personal Care Segment

 

For the Three Months Ended June 30,

   

For the Six Months Ended June 30,

 
   

2026

   

2025

   

2026

   

2025

 
           

% of Segment

           

% of Segment

           

% of Segment

           

% of Segment

 
   

Amount

   

Net Service

   

Amount

   

Net Service

   

Amount

   

Net Service

   

Amount

   

Net Service

 
   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

 

State, local and other governmental programs

  $ 148,822       50.3 %   $ 138,506       51.4 %   $ 288,457       50.0 %   $ 271,410       51.4 %

Managed care organizations

    139,285       47.1       121,900       45.3       272,959       47.3       238,907       45.3  

Private pay

    6,494       2.2       7,292       2.7       12,721       2.2       14,268       2.7  

Commercial insurance

    1,189       0.4       1,334       0.5       2,295       0.4       2,494       0.5  

Other

    205             151       0.1       657       0.1       390       0.1  

Total personal care segment net service revenues

  $ 295,995       100.0 %   $ 269,183       100.0 %   $ 577,089       100.0 %   $ 527,469       100.0 %

Illinois

    121,089       40.9 %     115,226       42.8 %     237,839       41.2 %     226,640       43.0 %

Texas

    59,139       20.0       52,464       19.5       116,529       20.2       102,324       19.4  

New Mexico

    31,962       10.8       28,987       10.8       62,452       10.8       57,292       10.9  

All other states

    83,805       28.3       72,506       26.9       160,269       27.8       141,213       26.7  

Total personal care segment net service revenues

  $ 295,995       100.0 %   $ 269,183       100.0 %   $ 577,089       100.0 %   $ 527,469       100.0 %

 

Hospice Segment

 

For the Three Months Ended June 30,

   

For the Six Months Ended June 30,

 
   

2026

   

2025

   

2026

   

2025

 
           

% of Segment

           

% of Segment

           

% of Segment

           

% of Segment

 
   

Amount

   

Net Service

   

Amount

   

Net Service

   

Amount

   

Net Service

   

Amount

   

Net Service

 
   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

 

Medicare

  $ 60,020       93.4 %   $ 57,846       93.0 %   $ 122,111       93.9 %   $ 114,638       92.7 %

Commercial insurance

    1,910       3.0       1,997       3.2       3,722       2.9       4,375       3.5  

Managed care organizations

    1,920       3.0       2,001       3.2       3,420       2.6       4,029       3.3  

Other

    397       0.6       368       0.6       779       0.6       607       0.5  

Total hospice segment net service revenues

  $ 64,247       100.0 %   $ 62,212       100.0 %   $ 130,032       100.0 %   $ 123,649       100.0 %

Ohio

  $ 24,207       37.7 %   $ 23,204       37.3 %   $ 50,674       39.0 %   $ 46,391       37.5 %

Illinois

    13,708       21.3       14,419       23.2       28,047       21.6       28,983       23.4  

New Mexico

    8,475       13.2       8,184       13.2       16,346       12.6       16,097       13.0  

All other states

    17,857       27.8       16,405       26.3       34,965       26.8       32,178       26.1  

Total hospice segment net service revenues

  $ 64,247       100.0 %   $ 62,212       100.0 %   $ 130,032       100.0 %   $ 123,649       100.0 %

 

24

 

Home Health Segment

 

For the Three Months Ended June 30,

   

For the Six Months Ended June 30,

 
   

2026

   

2025

   

2026

   

2025

 
           

% of Segment

           

% of Segment

           

% of Segment

           

% of Segment

 
   

Amount

   

Net Service

   

Amount

   

Net Service

   

Amount

   

Net Service

   

Amount

   

Net Service

 
   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

   

(in Thousands)

   

Revenues

 

Medicare

  $ 10,903       63.5 %   $ 12,517       69.4 %   $ 21,128       62.3 %   $ 25,094       69.7 %

Managed care organizations

    4,414       25.7       4,264       23.6       8,381       24.7       8,072       22.4  

State, local and other governmental programs (excluding Medicare)

    1,318       7.7       796       4.4       3,369       9.9       1,884       5.2  

Other

    540       3.1       471       2.6       1,029       3.1       983       2.7  

Total home health segment net service revenues

  $ 17,175       100.0 %   $ 18,048       100.0 %   $ 33,907       100.0 %   $ 36,033       100.0 %

New Mexico

  $ 9,166       53.4 %   $ 8,737       48.4 %   $ 17,705       52.2 %   $ 17,292       48.0 %

Tennessee

    6,533       38.0       7,322       40.6       13,417       39.6       14,820       41.1  

Illinois

    1,476       8.6       1,989       11.0       2,785       8.2       3,921       10.9  

Total home health segment net service revenues

  $ 17,175       100.0 %   $ 18,048       100.0 %   $ 33,907       100.0 %   $ 36,033       100.0 %

 

The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 32.1% and 33.0% of our net service revenues for the both the three and six months ended June 30, 2026 and 2025, respectively.

 

A significant amount of our net service revenues are derived from one payor, the Illinois Department on Aging, the largest payor program for our Illinois personal care operations, which accounted for 17.7% and 18.6% of our net service revenues for the three months ended June 30, 2026 and 2025, respectively, and accounted for 17.8% and 18.6% of our net service revenues for the six months ended June 30, 2026 and 2025, respectively.

 

Changes in Illinois Reimbursement

 

As noted above, we derive a significant amount of our net service revenues in Illinois. Changes to reimbursement rates and minimum wage requirements may materially impact our revenues. The Illinois fiscal year 2026 budget included an increase in hourly rates for in-home care services to $30.80, effective January 1, 2026, and required a minimum wage of $18.75 per hour for direct service workers. These rates remain stable under the Illinois fiscal year 2027 budget. CMS approved an amendment to Illinois’ Persons Who are Elderly waiver program that included the 2026 rate increase, effective January 1, 2026. Illinois’ current Persons Who are Elderly waiver expires September 30, 2026, unless CMS approves a renewal.

 

The City of Chicago requires the Chicago minimum wage to be adjusted annually based on increases in the Consumer Price Index (“CPI”), subject to a cap and other requirements. Effective July 1, 2026, the rate was adjusted to $17.05 based on the increase in the CPI.

 

Our business will benefit from the rate increases noted above for 2026, but there is no assurance that there will be additional rate increases in Illinois for fiscal years beyond fiscal year 2026 to offset increases in minimum wage, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.

 

Changes in Texas Reimbursement

 

The Texas fiscal year 2026 budget included an increase in hourly rates to $17.13 for in-home care services effective September 1, 2025.

 

25

 

Changes in Medicare Reimbursement

 

Hospice

 

Hospice services provided to Medicare beneficiaries are paid under the Medicare Hospice Prospective Payment System, under which CMS sets a daily rate for each day a patient is enrolled in the hospice benefit. The daily rate depends on the level of care provided to a patient (routine home care, continuous home care, inpatient respite care, or general inpatient care). Daily rates are adjusted for factors such as area wage levels. CMS updates hospice payment rates each federal fiscal year. Effective October 1, 2025, CMS increased hospice payment rates by 2.6%. This reflects a 3.3% market basket increase and a negative 0.7 percentage point productivity adjustment. Hospices that do not satisfy quality reporting requirements are subject to a 4-percentage point reduction to the market basket update.

 

Overall payments made by Medicare to each hospice provider number are subject to an inpatient cap and an aggregate cap. The inpatient cap limits the number of days of inpatient care for which Medicare will pay to no more than 20% of total patient care days. Days in excess of the limitation are paid at the routine home care rate. The aggregate cap limits the total Medicare reimbursement that a hospice may receive in a cap year (typically the federal fiscal year) based on an annual per-beneficiary cap amount, which is set each federal fiscal year, and the number of Medicare patients served. The per-beneficiary cap amount was updated to $35,361.44 for federal fiscal year 2026. If a hospice’s Medicare payments exceed its inpatient or aggregate caps, it must repay Medicare the excess amount.

 

Home Health

 

Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”), which uses national, standardized 30-day period payment rates for periods of care that meet a certain threshold of home health visits (periods of care that do not meet the visit threshold are paid a per-visit payment rate for the discipline providing care). Although payment is made for each 30-day period, the HHPPS permits continuous 60-day certification periods through which beneficiaries are verified as eligible for the home health benefit. The daily home health payment rate is adjusted for case-mix and area wage levels. CMS uses the Patient-Driven Groupings Model (“PDGM”) as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics and their resource needs. An outlier adjustment may be paid for periods of care where costs exceed a specific threshold amount.

 

CMS updates the HHPPS payment rates each calendar year. For calendar year 2026, CMS estimates that Medicare payments to home health agencies will decrease by 1.3%. This is based on a home health payment update percentage of 2.4%, which reflects a 3.2% market basket update, reduced by a productivity adjustment of 0.8 percentage points, among other changes. Home health providers that do not comply with quality data reporting requirements are subject to a 2-percentage point reduction to their market basket update. In addition, Medicare requires home health agencies to submit a one-time Notice of Admission (“NOA”) for each patient that establishes that the beneficiary is under a Medicare home health period of care. Failure to submit the NOA within five calendar days from the start of care will result in a reduction to the 30-day period payment amount for each day from the start of care date until the date the NOA is submitted.

 

Under the nationwide Home Health Value-Based Purchasing (“HHVBP”) Model, home health agencies receive increases or decreases to their Medicare fee-for-service payments of up to 5% based on performance against specific quality measures relative to the performance of other home health providers. Data collected in each performance year will impact Medicare payments two years later.

 

Payment of claims may be impacted by the Review Choice Demonstration for Home Health Services, a program intended to identify and prevent fraud, reduce the number of Medicare appeals and improve provider compliance with Medicare program requirements. The program is currently limited to home health agencies in Illinois, Ohio, Oklahoma, North Carolina, Florida, and Texas. Providers in states subject to the Review Choice Demonstration for Home Health Services may initially select either pre-claim review or post-payment review. Home health agencies that maintain high compliance levels are eligible for additional options that may be less burdensome. This program has not had a material impact on our results of operations or financial position.

 

26

 

CMS Final Rule: Ensuring Access to Medicaid Services

 

In May 2024, CMS finalized a rule intended to improve access to services and quality of care for Medicaid beneficiaries across fee-for-service and managed care delivery systems. The final rule includes significant provisions related to HCBS, including the “80/20” or “payment adequacy” requirement, which will require states to ensure by mid-2030 that at least 80% of all Medicaid payments a provider receives for homemaker, home health aide, and personal care services, less certain excluded costs, under specified programs are spent on total compensation (including benefits) for direct care workers furnishing these services, rather than administrative overhead or profit, subject to limited exceptions. The final rule includes several other measures intended to promote transparency and enhance quality and access to services, including a variety of reporting requirements for states. Given the long implementation period and the likelihood of further changes as a result of litigation, administration and congressional changes, further rule-making and state changes in response to the final rule, it is premature to predict the ultimate impact of the final rule on our business. Some states have adopted or may consider adopting similar caregiver compensation requirements.

 

Potential Developments

 

Home care and other healthcare providers may be significantly impacted by changes to the Medicaid program, including changes  resulting from legislation and administrative actions at the federal and state levels. Federal actions may impact funding for, or the structure of, the Medicaid program, including through changes to Medicaid waiver programs, and may shape provider reimbursement rates, eligibility and coverage policies, waiver programs and other aspects of state Medicaid programs at the state level. For example, the budget reconciliation legislation enacted on July 4, 2025, commonly known as the “One Big Beautiful Bill Act” (“OBBBA”), includes provisions that are expected to result in Medicaid spending reductions and changes in administration of state Medicaid programs. Among other changes, the law requires changes to Medicaid financing mechanisms, including restrictions intended to reduce the federal matching funds received by state Medicaid programs, with greater restrictions in states that have expanded Medicaid. In addition, some members of Congress and the executive branch have raised, and Congress in the future may adopt, other proposals intended to reduce Medicaid expenditures such as restructuring the Medicaid program to give states a “block grant” or fixed amount of overall funding for their respective Medicaid programs or to impose spending caps such as per Medicaid beneficiary limits on federal contributions. Reductions in federal funding or changes to the federal funding formula for Medicaid under the OBBBA or future initiatives could have a significant impact, particularly in states that expanded Medicaid under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “ACA”), and especially if federal contributions for Medicaid expansion populations decrease and states are unable to offset the reductions. Decreased federal funding and increased state obligations and administrative burden could strain state budgets, which could result in state limitations on Medicaid eligibility or coverage, payment rate reductions, and changes to Medicaid waiver programs, among other effects.

 

In addition, the President has issued executive orders that impact or may impact the healthcare industry. Further, some members of Congress and the presidential administration have raised potential measures intended to accelerate the shift from traditional Medicare to Medicare Advantage or eliminating some or all of the consumer protections established by the ACA.

 

CMS has increased program integrity efforts within the Medicare and Medicaid programs, including by withholding or deferring federal Medicaid funding in states that federal administrators determine do not have sufficient anti-fraud systems, which may delay or otherwise affect the reimbursement providers in affected states receive. In May 2026, CMS issued a six-month nationwide moratorium on new Medicare enrollments for hospices and home health agencies, temporarily restricting all new applications and branch expansions. The moratorium may also indirectly affect Medicaid enrollment in states requiring Medicare certification for Medicaid enrollment. The rule also requires a home health or hospice to submit an initial Medicare application if it experiences a change in majority ownership within 36 months after its initial enrollment or most recent change in majority ownership.

 

 

Components of our Statements of Income

 

Net Service Revenues

 

We generate net service revenues by providing our services directly to consumers and primarily on an hourly basis in our personal care segment, on a daily basis in our hospice segment, and on an episodic basis in our home health segment. We receive payment for providing such services from our private consumers and payors, including federal, state, and local governmental agencies, managed care organizations, and commercial insurers.

 

27

 

In our personal care segment, net service revenues are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate, which is either contractual or fixed by legislation, and are recognized at the time services are rendered. In our hospice segment, net service revenues are provided based on daily rates for each of the levels of care and are recognized as services are provided. In our home health segment, net service revenues are based on an episodic basis at a stated rate and recognized based on the number of days elapsed during a period of care within the reporting period. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record revenues.

 

Cost of Service Revenues

 

We incur direct care wages, payroll taxes, and benefit-related costs in connection with providing our services. We also provide workers’ compensation and general liability coverage for our employees. Employees are also reimbursed for their travel time and related travel costs in certain instances.

 

General and Administrative Expenses

 

Our general and administrative expenses include our costs for operating our network of local agencies and our administrative offices. Our agency expenses consist of costs for supervisory personnel, our community care supervisors, and office administrative costs. Personnel costs include wages, payroll taxes, and employee benefits. Facility costs include rents, utilities, and postage, telephone, and office expenses. Our corporate and support center expenses include costs for accounting, information systems, human resources, billing and collections, contracting, marketing, and executive leadership. These expenses consist of compensation, including stock-based compensation, payroll taxes, employee benefits, legal, accounting and other professional fees, travel, general insurance, rents, provision for doubtful accounts, and related facility costs. Expenses related to streamlining our operations such as costs related to terminated employees, termination of professional services relationships, other contract termination costs, and asset write-offs are also included in general and administrative expenses.

 

Depreciation and Amortization Expenses

 

Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment, and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if applicable, their lease terms. We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks, and non-competition agreements, using straight line or accelerated methods based upon their estimated useful lives.

 

Interest Expense

 

Interest expense is reported when incurred and principally consists of interest and unused credit line fees on the credit facility.

 

Income Tax Expense

 

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rates were 26.9% and 26.4% for the three months ended June 30, 2026 and 2025, respectively. The effective income tax rates were 25.0% and 24.0% for the six months ended June 30, 2026 and 2025, respectively, compared to our federal statutory rate of 21%. The difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, excess tax expense and the use of federal employment tax credits.

 

28

 

Results of Operations Consolidated

 

Three Months Ended June 30, 2026 Compared to Three Months Ended June 30, 2025

 

The following table sets forth our unaudited condensed consolidated results of operations.

 

   

For the Three Months Ended June 30,

                 
   

2026

   

2025

   

Change

 
           

% Of

           

% Of

                 
           

Net Service

           

Net Service

                 
   

Amount

   

Revenues

   

Amount

   

Revenues

   

Amount

   

%

 
   

(Amounts in Thousands, Except Percentages)

 

Net service revenues

  $ 377,417       100.0 %   $ 349,443       100.0 %   $ 27,974       8.0 %

Cost of service revenues

    255,857       67.8       235,566       67.4       20,291       8.6  

Gross profit

    121,560       32.2       113,877       32.6       7,683       6.7  

General and administrative expenses

    78,493       20.8       77,077       22.1       1,416       1.8  

Depreciation and amortization

    4,125       1.1       3,913       1.1       212       5.4  

Total operating expenses

    82,618       21.9       80,990       23.2       1,628       2.0  

Operating income

    38,942       10.3       32,887       9.4       6,055       18.4  

Interest income

    (566 )     (0.1 )     (583 )     (0.2 )     17       (2.9 )

Interest expense

    1,724       0.5       3,525       1.0       (1,801 )     (51.1 )

Total interest expense, net

    1,158       0.3       2,942       0.8       (1,784 )     (60.6 )

Income before income taxes

    37,784       10.0       29,945       8.6       7,839       26.2  

Income tax expense

    10,177       2.7       7,893       2.3       2,284       28.9  

Net income

  $ 27,607       7.3 %   $ 22,052       6.3 %   $ 5,555       25.2 %

 

Net service revenues increased by 8.0% to $377.4 million for the three months ended June 30, 2026 compared to $349.4 million for the three months ended June 30, 2025. Revenue increased by $26.8 million in our personal care segment, increased by $2.0 million in our hospice segment and decreased by $0.9 million in our home health segment during the three months ended June 30, 2026, compared to the same period in 2025. The increase in our personal care segment was primarily attributable to organic growth in billable hours combined with the HomeCourt Acquisition, the Gold Horses Acquisition and the Helping Hands Acquisition. The increase in our hospice segment revenue was due to organic growth. The decrease in our home health segment was primarily attributed to lower patient volumes.

 

Gross profit, expressed as a percentage of net service revenues, was 32.2% for the three months ended June 30, 2026, compared to 32.6% for the same period in 2025

 

General and administrative expenses increased to $78.5 million for the three months ended June 30, 2026, compared to $77.1 million for the three months ended June 30, 2025. The increase in general and administrative expenses was primarily due to acquisition activity, including the HomeCourt Acquisition, the Gold Horses Acquisition and the Helping Hands Acquisition, which contributed to an increase in administrative employee wage, bonus, tax, and benefit costs of $4.0 million, partially offset by a $1.7 million decrease in professional fees and other decreases in general and administrative expenses. General and administrative expenses, expressed as a percentage of net service revenues, were 20.8% for the three months ended June 30, 2026, compared to 22.1% for the three months ended June 30, 2025.

 

Interest expense decreased to $1.7 million for the three months ended June 30, 2026 from $3.5 million for the three months ended June 30, 2025. The decrease in interest expense was primarily due to lower average outstanding borrowings and a lower weighted average interest rate under our credit facility for the three months ended June 30, 2026, compared to the three months ended June 30, 2025.

 

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 26.9% and 26.4% for the three months ended June 30, 2026 and 2025, respectively. Our higher effective income tax rate for the three months ended June 30, 2026 was principally due to a lower excess tax expense with a lower benefit from the use of federal employment tax credits. For the three months ended June 30, 2026 and 2025, the excess tax benefit and federal employment tax credits were 1.2% and 2.6%, respectively.

 

29

 

Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025

 

The following table sets forth our unaudited condensed consolidated results of operations.

 

   

For the Six Months Ended June 30,

                 
   

2026

   

2025

   

Change

 
           

% Of

           

% Of

                 
           

Net Service

           

Net Service

                 
   

Amount

   

Revenues

   

Amount

   

Revenues

   

Amount

      %
   

(Amounts in Thousands, Except Percentages)

 

Net service revenues

  $ 741,028       100.0 %   $ 687,151       100.0 %   $ 53,877       7.8 %

Cost of service revenues

    503,595       68.0       465,597       67.8       37,998       8.2  

Gross profit

    237,433       32.0       221,554       32.2       15,879       7.2  

General and administrative expenses

    156,264       21.1       150,297       21.9       5,967       4.0  

Depreciation and amortization

    8,155       1.1       7,856       1.1       299       3.8  

Total operating expenses

    164,419       22.2       158,153       23.0       6,266       4.0  

Operating income

    73,014       9.9       63,401       9.2       9,613       15.2  

Interest income

    (1,076 )     (0.1 )     (1,085 )     (0.2 )     9       (0.8 )

Interest expense

    3,875       0.5       7,543       1.1       (3,668 )     (48.6 )

Total interest expense, net

    2,799       0.4       6,458       0.9       (3,659 )     (56.7 )

Income before income taxes

    70,215       9.5       56,943       8.3       13,272       23.3  

Income tax expense

    17,539       2.4       13,663       2.0       3,876       28.4  

Net income

  $ 52,676       7.1 %   $ 43,280       6.3 %   $ 9,396       21.7 %

 

Net service revenues increased by 7.8% to $741.0 million for the six months ended June 30, 2026 compared to $687.2 million for the six months ended June 30, 2025. Revenue increased by $49.6 million in our personal care segment, increased by $6.4 million in our hospice segment and decreased by $2.1 million in our home health segment during the six months ended June 30, 2026, compared to the same period in 2025. The increase in our personal care segment was primarily attributable to organic growth in billable hours combined with the HomeCourt Acquisition, the Gold Horses Acquisition and the Helping Hands Acquisition. The increase in our hospice segment revenue was due to organic growth. The decrease in our home health segment was primarily attributed to lower patient volumes.

 

Gross profit, expressed as a percentage of net service revenues, was 32.0% for the six months ended June 30, 2026, compared to 32.2% for the same period in 2025

 

General and administrative expenses increased to $156.3 million for the six months ended June 30, 2026, compared to $150.3 million for the six months ended June 30, 2025. The increase in general and administrative expenses was primarily due to acquisition activity, including the HomeCourt Acquisition, the Gold Horses Acquisition and the Helping Hands Acquisition, which contributed to an increase in administrative employee wage, bonus, tax, and benefit costs of $7.4 million, partially offset by a $1.9 million decrease in professional fees and other decreases in general and administrative expenses. General and administrative expenses, expressed as a percentage of net service revenues, were 21.1% for the six months ended June 30, 2026, compared to 21.9% for the six months ended June 30, 2025.

 

Interest expense decreased to $3.9 million for the six months ended June 30, 2026 from $7.5 million for the six months ended June 30, 2025. The decrease in interest expense was primarily due to lower average outstanding borrowings and a lower weighted average interest rate under our credit facility for the six months ended June 30, 2026, compared to the six months ended June 30, 2025.

 

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 25.0% and 24.0% for the six months ended June 30, 2026 and 2025, respectively. Our higher effective income tax rate for the six months ended June 30, 2026, was principally due to a lower excess tax benefit with a lower benefit from the use of federal employment tax credits. For the six months ended June 30, 2026 and 2025, the excess tax benefit and federal employment tax credits were 3.1% and 4.8%, respectively.

 

30

 

Results of Operations Segments

 

The following tables and related analysis summarize our operating results and business metrics by segment:

 

Personal Care Segment

 

   

For the Three Months Ended June 30,

   

For the Six Months Ended June 30,

 
   

2026

   

2025

   

Change

   

2026

   

2025

   

Change

 
           

% of

           

% of

                           

% of

           

% of

                 
           

Segment

           

Segment

                           

Segment

           

Segment

                 
           

Net Service

           

Net Service

                           

Net Service

           

Net Service

                 
   

Amount

   

Revenues

   

Amount

   

Revenues

   

Amount

      %  

Amount

   

Revenues

   

Amount

   

Revenues

   

Amount

      %
   

(Amounts in Thousands, Except Percentages)

   

(Amounts in Thousands, Except Percentages)

 

Operating Results

                                                                                               

Net service revenues

  $ 295,995       100.0 %   $ 269,183       100.0 %   $ 26,812       10.0 %   $ 577,089       100.0 %   $ 527,469       100.0 %   $ 49,620       9.4 %

Cost of services revenues

    210,351       71.1       193,380       71.8       16,971       8.8       413,625       71.7       380,344       72.1       33,281       8.8  

Gross profit

    85,644       28.9       75,803       28.2       9,841       13.0       163,464       28.3       147,125       27.9       16,339       11.1  

General and administrative expenses

    25,264       8.5       24,163       9.0       1,101       4.6       50,218       8.7       47,894       9.1       2,324       4.9  

Segment operating income

  $ 60,380       20.4 %   $ 51,640       19.2 %   $ 8,740       16.9 %   $ 113,246       19.6 %   $ 99,231       18.8 %   $ 14,015       14.1 %

Business Metrics (Actual Numbers, Except Billable Hours in Thousands)

                                                                                               

Locations at period end

                                                    202               199                          

Average billable census * (1)

    51,097               50,404               693       1.4 %     50,823               50,442               381       0.8 %

Billable hours * (2)

    11,145               10,558               587       5.6       21,878               20,760               1,118       5.4  

Average billable hours per census per month * (2)

    72.9               69.8               3.1       4.4       72.1               68.6               3.5       5.1  

Billable hours per business day * (2)

    171,469               162,436               9,033       5.6       169,599               160,927               8,672       5.4  

Revenues per billable hour * (2)

  $ 26.55             $ 25.49             $ 1.06       4.2 %   $ 26.36             $ 25.41             $ 0.95       3.7 %

Same store growth revenue % * (3)

    6.8 %             7.4 %             (0.6 )     (8.1 )     6.7 %             7.4 %             (0.7 )     (9.5 )

 

(1)

Average billable census is the number of unique clients receiving a billable service during the period and is the total census divided by months in operation during the period.

 

(2)

Billable hours is the total number of hours served to clients during the period. Average billable hours per census per month is billable hours divided by average billable census. Billable hours per day is total billable hours divided by the number of business days in the period. Revenues per billable hour is revenue, attributed to billable bonus hours, divided by billable hours.

 

(3)

Same store growth reflects the change in year-over-year revenue for the same store base. We define the same store base to include those stores open for at least 52 full weeks. This measure highlights the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures and ARPA associated revenue from this calculation.

 

31

 

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

 

The personal care segment derives a significant amount of its net service revenues from operations in Illinois, which represented 32.1% and 33.0% of our net service revenues for both the three and six months ended June 30, 2026 and 2025, respectively. One payor, the Illinois Department on Aging, accounted for 17.7% and 18.6% of net service revenues for the three months ended June 30, 2026 and 2025, respectively, and accounted for 17.8% and 18.6% of net service revenues for the six months ended June 30, 2026 and 2025, respectively.

 

Net service revenues from state, local, and other governmental programs accounted for 50.3% and 51.4% of net service revenues for the three months ended June 30, 2026 and 2025, respectively. Managed care organizations accounted for 47.1% and 45.3% of net service revenues for the three months ended June 30, 2026 and 2025, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues. Net service revenues from state, local, and other governmental programs accounted for 50.0% and 51.4% of net service revenues for the six months ended June 30, 2026 and 2025, respectively. Managed care organizations accounted for 47.3% and 45.3% of net service revenues for the six months ended June 30, 2026 and 2025, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues.

 

Net service revenues increased by 10.0% and 9.4% for the three and six months ended June 30, 2026 respectively, compared to the three and six months ended June 30, 2025. Net service revenues reflected a 5.6% and 5.4% increase in billable hours and a 4.2% and 3.7% increase in revenues per billable hour for the three and six months ended June 30, 2026, respectively.

 

Gross profit, expressed as a percentage of net service revenues, was 28.9% for the three months ended June 30, 2026 from 28.2% for the three months ended 2025 and increased to 28.3% for the six months ended June 30, 2026 from 27.9% for the six months ended June 30, 2025. The increases primarily reflected higher revenues per billable hour.

 

The personal care segment’s general and administrative expenses primarily consist of administrative employee wages, taxes, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, were 8.5% and 9.0% for the three months ended June 30, 2026 and 2025, respectively, and 8.7% and 9.1% for the six months ended June 30, 2026 and 2025, respectively.

 

32

 

Hospice Segment

 

   

For the Three Months Ended June 30,

   

For the Six Months Ended June 30,

 
   

2026

   

2025

   

Change

   

2026

   

2025

   

Change

 
           

% of

           

% of

                           

% of

           

% of

                 
           

Segment

           

Segment

                           

Segment

           

Segment

                 
           

Net Service

           

Net Service

                           

Net Service

           

Net Service

                 
   

Amount

   

Revenues

   

Amount

   

Revenues

   

Amount

      %  

Amount

   

Revenues

   

Amount

   

Revenues

   

Amount

      %
   

(Amounts in Thousands, Except Percentages)

   

(Amounts in Thousands, Except Percentages)

 

Operating Results

                                                                                               

Net service revenues

  $ 64,247       100.0 %   $ 62,212       100.0 %   $ 2,035       3.3 %   $ 130,032       100.0 %   $ 123,649       100.0 %   $ 6,383       5.2 %

Cost of services revenues

    35,976       56.0       32,414       52.1       3,562       11.0       71,284       54.8       64,684       52.3       6,600       10.2  

Gross profit

    28,271       44.0       29,798       47.9       (1,527 )     (5.1 )     58,748       45.2       58,965       47.7       (217 )     (0.4 )

General and administrative expenses

    16,166       25.2       14,976       24.1       1,190       7.9       31,991       24.6       29,526       23.9       2,465       8.3  

Segment operating income

  $ 12,105       18.8 %   $ 14,822       23.8 %   $ (2,717 )     (18.3 )%   $ 26,757       20.6 %   $ 29,439       23.8 %   $ (2,682 )     (9.1 )%

Business Metrics (Actual Numbers)

                                                                                               

Locations at period end

                                                    40               38                          

Admissions * (1)

    3,247               3,260               (13 )     (0.4 )%     6,664               6,734               (70 )     (1.0 )%

Average daily census * (2)

    3,964               3,720               244       6.6       3,899               3,618               281       7.8  

Average discharge length of stay * (3)

    100.1               90.6               9.5       10.5       105.5               94.1               11.4       12.1  

Patient days * (4)

    360,692               338,505               22,187       6.6       703,051               654,824               48,227       7.4  

Revenue per patient day * (5)

  $ 190.66             $ 184.92             $ 5.74       3.1     $ 191.03             $ 189.42             $ 1.61       0.8  

Organic growth

                                                                                               

- Revenue * (6)

    11.1 %             10.0 %             1.1       11.0       9.4 %             9.9 %             (0.5 )     (5.1 )

- Average daily census * (6)

    6.5 %             7.0 %             (0.5 )     (7.1 )%     7.6 %             5.8 %             1.8       31.0 %

 

(1)

Represents referral process and new patients on service during the period.

 

(2)

Average daily census is total patient days divided by the number of days in the period.

 

(3)

Average length of stay is the average number of days a patient is on service, calculated upon discharge, and is total patient days divided by total discharges in the period.

 

(4)

Patient days is days of service for all patients in the period.

 

(5)

Revenue per patient day is hospice revenue divided by the number of patient days in the period. Hospice revenue excludes the impact of one-time adjustments such as ARPA, Medicare cap or specific situational reserves.

 

(6)

Revenue organic growth and average daily census organic growth reflect the change in year-over-year revenue and average daily census for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of one-time adjustments such as ARPA, Medicare cap or specific situational reserves as well as acquisitions, new store openings and closures.

 

33

 

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

 

The hospice segment generates revenue by providing care to patients with a life expectancy of six months or less, as well as related services for their families. Hospice offers four levels of care, as defined by Medicare, to meet the varying needs of patients and their families. The four levels of hospice include routine home care, continuous home care, general inpatient care and respite care. Our hospice segment principally provides routine home care.

 

Net service revenues from Medicare accounted for 93.4% and 93.0% for the three months ended June 30, 2026 and 2025, respectively, and 93.9% and 92.7% for the six months ended June 30, 2026 and 2025, respectively. Net service revenues from managed care organizations accounted for 3.0% and 3.2% for the three months ended June 30, 2026 and 2025, respectively, and for 2.6% and 3.3% for the six months ended June 30, 2026 and 2025, respectively.

 

Net service revenues increased by 3.3% and 5.2% for the three and six months ended June 30, 2026, respectively, compared to the three and six months ended June 30, 2025. Net services revenues included organic growth in average daily census and higher revenues per patient day.

 

Gross profit, expressed as a percentage of net service revenues, was 44.0% and 47.9% for the three months ended June 30, 2026 and 2025, respectively, and 45.2% and 47.7% for the six months ended June 30, 2026 and 2025, respectively. The decreases were primarily attributable to an increase in direct wages, taxes and benefit costs as a percentage of net service revenues.

 

The hospice segment’s general and administrative expenses primarily consist of administrative employee wage, tax, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 25.2% and 24.1% for the three months ended June 30, 2026 and 2025, respectively, and 24.6% and 23.9% for the six months ended June 30, 2026 and 2025, respectively. 

 

34

 

Home Health Segment

 

   

For the Three Months Ended June 30,

   

For the Six Months Ended June 30,

 
   

2026

   

2025

   

Change

   

2026

   

2025

   

Change

 
           

% of

           

% of

                           

% of

           

% of

                 
           

Segment

           

Segment

                           

Segment

           

Segment

                 
           

Net Service

           

Net Service

                           

Net Service

           

Net Service

                 
   

Amount

   

Revenues

   

Amount

   

Revenues

   

Amount

      %  

Amount

   

Revenues

   

Amount

   

Revenues

   

Amount

      %
   

(Amounts in Thousands, Except Percentages)

   

(Amounts in Thousands, Except Percentages)

 

Operating Results

                                                                                               

Net service revenues

  $ 17,175       100.0 %   $ 18,048       100.0 %   $ (873 )     (4.8 )%   $ 33,907       100.0 %   $ 36,033       100.0 %   $ (2,126 )     (5.9 )%

Cost of services revenues

    9,530       55.5       9,771       54.1       (241 )     (2.5 )     18,686       55.1       20,569       57.1       (1,883 )     (9.2 )

Gross profit

    7,645       44.5       8,277       45.9       (632 )     (7.6 )     15,221       44.9       15,464       42.9       (243 )     (1.6 )

General and administrative expenses

    4,358       25.4       3,895       21.6       463       11.9       8,771       25.9       8,068       22.4       703       8.7  

Segment operating income

  $ 3,287       19.1 %   $ 4,382       24.3 %   $ (1,095 )     (25.0 )%   $ 6,450       19.0 %   $ 7,396       20.5 %   $ (946 )     (12.8 )%

Business Metrics (Actual Numbers)

                                                                                               

Locations at period end

                                                    22               23                          

New admissions * (1)

    5,016               4,568               448       9.8 %     9,710               9,276               434       4.7 %

Recertifications * (2)

    2,785               2,833               (48 )     (1.7 )     5,308               5,815               (507 )     (8.7 )

Total volume * (3)

    7,801               7,401               400.0       5.4       15,018               15,091               (73.0 )     (0.5 )

Visits * (4)

    88,516               94,692               (6,176 )     (6.5 )     169,408               189,285               (19,877 )     (10.5 )

Organic growth

                                                                                               

- Revenue * (5)

    (2.8 )%             (6.0 )%             3.2       (53.3 )     (4.7 )%             (2.5 )%             (2.2 )     88.0  

- Admissions * (5)

    9.8 %             (7.6 )%             17.4       (228.9 )%     4.7 %             (5.6 )%             10.3       (183.9 )%

 

(1)

Represents new patients during the period.

 

(2)

A home health certification period is an episode of care that begins with a start of care visit and continues for 60 days. If at the end of the initial episode of care, the patient continues to require home health services, a recertification is required. This represents the number of recertifications during the period.

 

(3)

Total volume is total admissions and total recertifications in the period.

 

(4)

Represents number of services to patients in the period.

 

(5)

Revenue organic growth and admissions organic growth reflect the change in year-over-year revenue and admissions for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of one-time adjustments such as specific situational reserves as well as acquisitions, new store openings and closures.

 

35

 

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

 

The home health segment generates net service revenues by providing home health services on a short-term, intermittent or episodic basis to individuals, generally to treat an illness or injury. Net service revenues from Medicare accounted for 63.5% and 69.4%, managed care organizations accounted for 25.7% and 23.6%, and state, local, and other governmental programs accounted for 7.7% and 4.4% for the three months ended June 30, 2026 and 2025, respectively. Net service revenues from Medicare accounted for 62.3% and 69.7%, managed care organizations accounted for 24.7% and 22.4%, and state, local, and other governmental programs accounted for 9.9% and 5.2% for the six months ended June 30, 2026 and 2025, respectively. Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System, which uses national, standardized 30-day period payment rates for periods of care. CMS uses the PDGM as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics. An outlier adjustment may be paid for periods of care in which costs exceed a specific threshold amount.

 

Net service revenues decreased by 4.8% and 5.9% for the three and six months ended June 30, 2026, respectively, compared to the three and six months ended June 30, 2025. Net service revenues primarily reflected lower patient visits, partially offset by a favorable payor mix. 

 

Gross profit, expressed as a percentage of net service revenues, was 44.5% and 45.9% for the three months ended June 30, 2026 and 2025, respectively, and 44.9% and 42.9% for the six months ended June 30, 2026 and 2025, respectively. The decrease for the three months ended June 30, 2026 was primarily attributable to an increase in direct wages, taxes and benefit costs as a percentage of net service revenues. The increase for the six months ended June 30, 2026 was primarily attributable to a decrease in direct wages, taxes and benefit costs as a percentage of net service revenues.

 

The home health segment’s general and administrative expenses primarily consist of administrative employee wage, tax and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, were 25.4% and 21.6% for the three months ended June 30, 2026 and 2025, respectively, and 25.9% and 22.4% for the six months ended June 30, 2026 and 2025, respectively. 

 

Liquidity and Capital Resources

 

Overview

 

Our primary sources of liquidity are cash on hand and cash from operations and borrowings under our credit facility. At June 30, 2026 and December 31, 2025, we had cash balances of $99.6 million and $81.6 million, respectively. At June 30, 2026, we had a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility was extended to July 30, 2028.

 

During the six months ended June 30, 2026, we repaid $60.0 million under our revolving credit facility. As of June 30, 2026, we had a total of $64.3 million in revolving loans, with an interest rate of 5.40% outstanding on our credit facility and after giving effect to the amount drawn on our credit facility, approximately $7.9 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), we had $650.0 million of capacity and $577.8 million available for borrowing under our credit facility. At December 31, 2025, we had a total of $124.3 million revolving credit loans, with an interest rate of 5.48%, outstanding on our credit facility.

 

36

 

Our credit facility requires us to maintain a total net leverage ratio not exceeding 3.75:1.00. At June 30, 2026, we were in compliance with our financial covenants under the Credit Agreement. Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility. Additionally, there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.

 

See Note 8 to the Notes to Unaudited Condensed Consolidated Financial Statements, Long-Term Debt, for additional details of our long-term debt.

 

Current Macroeconomic Conditions and American Rescue Plan Act of 2021 Relief Funding

 

Economic conditions in the United States continue to be challenging in various respects. For example, the United States economy continues to experience inflationary pressures, elevated interest rates, challenging labor market conditions and uncertainty regarding the impact of increased tariffs and trade disruptions. Any economic downturn would pose a risk to states’ revenues, which in turn could affect our reimbursements and collections received for services rendered. Depending on the severity and length of any potential economic downturn as well as the extent of any federal support, states could face significant fiscal challenges and revise their revenue forecasts and adjust their budgets, and sales tax collections and income tax withholdings could be depressed.

 

ARPA Spending Plans

 

To mitigate the fiscal effects of the COVID-19 public health emergency, the ARPA provided for a 10 percentage point increase in federal matching funds for Medicaid HCBS from April 1, 2021, through March 31, 2022, provided the states satisfied certain conditions. States must submit periodic HCBS spending plans to CMS regarding the federal and state funds tied to the increase in federal matching funds. Although states were generally permitted to use the associated state funds by March 31, 2025, CMS granted extensions to several states and some state spending plans continue through September 30, 2026.

 

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company participates include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

 

During the three and six months ended June 30, 2026, the Company received additional state funding provided by the ARPA of $0.1 million and $6.3 million, respectively. Of the total state funding received by the Company pursuant to the ARPA through June 30, 2026, the Company utilized $2.4 million and $5.6 million during the three and six months ended June 30, 2026, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2026, the deferred portion of ARPA funding of $12.4 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

 

The following table summarizes changes in our cash flows:

 

   

For the Six Months Ended June 30,

 
   

2026

   

2025

 
   

(Amounts in Thousands)

 

Net cash provided by operating activities

  $ 92,376     $ 41,478  

Net cash (used in) provided by investing activities

    (15,197 )     317  

Net cash used in financing activities

    (59,230 )     (49,530 )

 

37

 

Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025

 

Cash flows from operating activities represent the inflow of cash from our payors and the outflow of cash for payroll and payroll taxes, operating expenses, interest, and taxes. Net cash provided by operating activities was $92.4 million for the six months ended June 30, 2026, compared to net cash provided by operating activities of $41.5 million for the same period in 2025. The increase in cash provided by operations was primarily due to the timing of receipts on accounts receivable and the timing of payments related to payroll and accounts payable. The changes in accounts receivable were primarily related to the growth in revenue and a decrease in days sales outstanding (“DSO”) during the six months ended June 30, 2026 as compared to the six months ended June 30, 2025. The related receivables due from the Illinois Department on Aging represented 13.2% and 18.6% of the Company’s net accounts receivable at June 30, 2026 and June 30, 2025, respectively.

 

Net cash used in investing activities for the six months ended June 30, 2026, primarily consisted of $12.2 million of net cash used for the HomeCourt Acquisition and $3.1 million of cash used for property and equipment purchases, primarily related to our ongoing investments in technology infrastructure fixed assets. Net cash used in investing activities for the six months ended June 30, 2025 primarily consisted of $3.4 million of net cash used for the Jacksonville Acquisition and the Great Lakes Acquisition, $3.1 million of cash used for property and equipment purchases, primarily related to our ongoing investments in technology infrastructure fixed assets, offset by $3.8 million in proceeds received relating to the New York Asset Sale and $2.9 million in proceeds received relating to the December 2024 acquisition of the personal care business of Curo Health Services, LLC, a Delaware limited liability company that does business as Gentiva.

 

Net cash used in financing activities for the six months ended June 30, 2026, primarily consisted of $60.0 million payment on our revolving credit facility, offset by cash received from the exercise of stock options of $0.8 million. Net cash used in financing activities for the six months ended June 30, 2025 primarily consisted of $50.0 million payment on our revolving credit facility, offset by cash received from the exercise of stock options of $0.5 million.

 

Outstanding Accounts Receivable

 

Outstanding accounts receivable, net of the allowance for credit losses as of June 30, 2026 and December 31, 2025 were approximately $145.1 million and $151.7 million, respectively, decreased by $6.6 million as of June 30, 2026 as compared to December 31, 2025. Accounts receivable for the Illinois Department on Aging decreased approximately $18.6 million during the six months ended June 30, 2026. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted.

 

We calculate our DSO by taking the trade accounts receivable outstanding, net of allowance for credit losses for doubtful accounts, divided by the net service revenues for the last quarter, multiplied by the number of days in that quarter. Our DSOs were 36 days and 38 days at June 30, 2026 and December 31, 2025, respectively. The DSOs for our largest payor, the Illinois Department on Aging, were 27 days and 55 days at June 30, 2026 and December 31, 2025, respectively.

 

Off-Balance Sheet Arrangements

 

As of June 30, 2026, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.

 

Critical Accounting Policies and Estimates

 

There have been no material changes to our critical accounting policies and estimates previously disclosed under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” set forth in Part II, Item 7 of our Annual Report on Form 10-K for the period ended December 31, 2025, filed with the SEC.

 

Recently Issued Accounting Pronouncements

 

Refer to Note 2 to the Notes to Unaudited Condensed Consolidated Financial Statements for further discussion.

 

38

 

ITEM 3.       QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are exposed to market risk associated with changes in interest rates on our variable rate long-term debt. As of June 30, 2026, we had outstanding borrowings of approximately $64.3 million on our credit facility, and all of such borrowings were subject to variable interest rates. If the variable rates on this debt were 100 basis points higher than the rate applicable to the borrowing during the six-month period ended June 30, 2026, our net income would have decreased by $0.4 million, or $0.02 per diluted share. We do not currently have any derivative or hedging arrangements, or other known exposures, to changes in interest rates.

 

ITEM 4.       CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2026. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2026.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the fiscal quarter ended June 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

39

 

 

PART II OTHER INFORMATION

 

Item 1.         Legal Proceedings

 

Legal Proceedings

 

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our financial position and results of operations.

 

 

Item 1A.      Risk Factors

 

Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors discussed under the caption “Risk Factors” set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC. There have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or operating results.

 

 

Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

 

Item 3.         Defaults Upon Senior Securities

 

None.

 

 

Item 4.         Mine Safety Disclosures

 

None.

 

 

Item 5.         Other Information

 

Not applicable. Without limiting the generality of the foregoing, during the quarter ended June 30, 2026, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, as such terms are defined in Item 408(a) of Regulation S-K.

 

40

 
 

Item 6.         Exhibits

EXHIBIT INDEX

 

       

Incorporated by Reference

Exhibit

Number

 

Description of Document

 

Form

 

File No.

 

Date Filing

 

Exhibit

Number

                     

3.1

 

Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009.

 

10-Q

 

001-34504

 

11/20/2009

 

3.1

                     

3.2

 

Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws.

 

10-Q

 

001-34504

 

05/09/2013

 

3.2

                     

4.1

 

Form of Common Stock Certificate.

 

S-1

 

333-160634

 

10/02/2009

 

4.1

                     

31.1

 

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

               
                     

31.2

 

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

               
                     

32.1

 

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

               
                     

32.2

 

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

               
                     

101.INS

  

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

               
                     

101.SCH

  

Inline XBRL Taxonomy Extension Schema Document.

               
                     

101.CAL

  

Inline XBRL Taxonomy Calculation Linkbase Document.

               
                     

101.LAB

  

Inline XBRL Taxonomy Label Linkbase Document.

               
                     

101.PRE

  

Inline XBRL Presentation Linkbase Document.

               
                     

101.DEF

  

Inline XBRL Taxonomy Extension Definition Linkbase Document.

               
                     

104

  

Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

               

 

41

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

ADDUS HOMECARE CORPORATION

     

Date: August 4, 2026

By:

/s/ R. DIRK ALLISON

     
 

 

R. Dirk Allison

Chairman and Chief Executive Officer

(As Principal Executive Officer)

     

Date: August 4, 2026

By:

/s/ BRIAN POFF

     
   

Brian Poff

Chief Financial Officer

(As Principal Financial Officer)

 

42